{ "version": "2.2", "instance": { "f20fa_071626.htm": { "nsprefix": "ptgef", "nsuri": "http://portagebiotech.com/20260331", "dts": { "inline": { "local": [ "f20fa_071626.htm" ] }, "schema": { "local": [ "ptgef-20260331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd" ] }, "calculationLink": { "local": [ "ptgef-20260331_cal.xml" ] }, "definitionLink": { "local": [ "ptgef-20260331_def.xml" ], "remote": [ "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml" ] }, "labelLink": { "local": [ "ptgef-20260331_lab.xml" ] }, "presentationLink": { "local": [ "ptgef-20260331_pre.xml" ] } }, "keyStandard": 172, "keyCustom": 365, "axisStandard": 20, "axisCustom": 0, "memberStandard": 9, "memberCustom": 92, "hidden": { "total": 880, "http://portagebiotech.com/20260331": 645, "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 230, "http://xbrl.sec.gov/dei/2025": 5 }, "contextCount": 349, "entityCount": 1, "segmentCount": 110, "elementCount": 766, "unitCount": 4, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 707, "http://xbrl.sec.gov/dei/2025": 45 }, "report": { "R1": { "role": "http://portagebiotech.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R2": { "role": "http://portagebiotech.com/role/StatementsOfFinancialPosition", "longName": "00000002 - Statement - Consolidated Statements of Financial Position", "shortName": "Consolidated Statements of Financial Position", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:RestrictedCashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R3": { "role": "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss", "longName": "00000003 - Statement - Consolidated Statements of Operations and Other Comprehensive Income (Loss)", "shortName": "Consolidated Statements of Operations and Other Comprehensive Income (Loss)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DepreciationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R4": { "role": "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit", "longName": "00000004 - Statement - Consolidated Statements of Changes in Equity (Deficit)", "shortName": "Consolidated Statements of Changes in Equity (Deficit)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2023-03-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-03-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R5": { "role": "http://portagebiotech.com/role/StatementsOfCashFlows", "longName": "00000005 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-04-012024-03-31", "name": "ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R6": { "role": "http://portagebiotech.com/role/NatureOfOperations", "longName": "999006 - Disclosure - NATURE OF OPERATIONS", "shortName": "NATURE OF OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:NatureOfOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:NatureOfOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R7": { "role": "http://portagebiotech.com/role/GoingConcern", "longName": "999007 - Disclosure - GOING CONCERN", "shortName": "GOING CONCERN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfGoingConcernExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfGoingConcernExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R8": { "role": "http://portagebiotech.com/role/BasisOfPresentation", "longName": "999008 - Disclosure - BASIS OF PRESENTATION", "shortName": "BASIS OF PRESENTATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R9": { "role": "http://portagebiotech.com/role/SignificantAccountingPolicies", "longName": "999009 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R10": { "role": "http://portagebiotech.com/role/PrepaidExpensesOtherReceivablesAndOtherAssets", "longName": "999010 - Disclosure - PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS", "shortName": "PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R11": { "role": "http://portagebiotech.com/role/Stablecoin", "longName": "999011 - Disclosure - STABLECOIN", "shortName": "STABLECOIN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfStablecoinExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfStablecoinExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R12": { "role": "http://portagebiotech.com/role/DigitalAssets", "longName": "999012 - Disclosure - DIGITAL ASSETS", "shortName": "DIGITAL ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfDigitalAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfDigitalAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R13": { "role": "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssets", "longName": "999013 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS", "shortName": "PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:PropertyPlantAndEquipmentAndRightOfUseAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:PropertyPlantAndEquipmentAndRightOfUseAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R14": { "role": "http://portagebiotech.com/role/InvestmentInCompedica", "longName": "999014 - Disclosure - INVESTMENT IN COMPEDICA", "shortName": "INVESTMENT IN COMPEDICA", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R15": { "role": "http://portagebiotech.com/role/WarrantLiability", "longName": "999015 - Disclosure - WARRANT LIABILITY", "shortName": "WARRANT LIABILITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfWarrantLiabilityExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfWarrantLiabilityExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R16": { "role": "http://portagebiotech.com/role/PutRightLiabilityAndTonPayable", "longName": "999016 - Disclosure - PUT RIGHT LIABILITY AND TON PAYABLE", "shortName": "PUT RIGHT LIABILITY AND TON PAYABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R17": { "role": "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilities", "longName": "999017 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:AccountsPayableAndAccruedLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:AccountsPayableAndAccruedLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R18": { "role": "http://portagebiotech.com/role/LeaseLiability", "longName": "999018 - Disclosure - LEASE LIABILITY", "shortName": "LEASE LIABILITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfLeaseLiabilityExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfLeaseLiabilityExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R19": { "role": "http://portagebiotech.com/role/BitgoPrimeLoan", "longName": "999019 - Disclosure - BITGO PRIME LOAN", "shortName": "BITGO PRIME LOAN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfBitgoPrimeLoanExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfBitgoPrimeLoanExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R20": { "role": "http://portagebiotech.com/role/IncomeTaxes", "longName": "999020 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R21": { "role": "http://portagebiotech.com/role/CapitalStockAndReserves", "longName": "999021 - Disclosure - CAPITAL STOCK AND RESERVES", "shortName": "CAPITAL STOCK AND RESERVES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:CapitalStockAndReservesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:CapitalStockAndReservesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R22": { "role": "http://portagebiotech.com/role/StockOptionReserve", "longName": "999022 - Disclosure - STOCK OPTION RESERVE", "shortName": "STOCK OPTION RESERVE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R23": { "role": "http://portagebiotech.com/role/LossPerShare", "longName": "999023 - Disclosure - LOSS PER SHARE", "shortName": "LOSS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R24": { "role": "http://portagebiotech.com/role/CommitmentsAndContingentLiabilities", "longName": "999024 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R25": { "role": "http://portagebiotech.com/role/RelatedPartyTransactions", "longName": "999025 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R26": { "role": "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagement", "longName": "999026 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R27": { "role": "http://portagebiotech.com/role/SegmentReporting", "longName": "999027 - Disclosure - SEGMENT REPORTING", "shortName": "SEGMENT REPORTING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfSegmentReportingExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfSegmentReportingExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R28": { "role": "http://portagebiotech.com/role/CapitalManagement", "longName": "999028 - Disclosure - CAPITAL MANAGEMENT", "shortName": "CAPITAL MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfCapitalManagementExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfCapitalManagementExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R29": { "role": "http://portagebiotech.com/role/Non-controllingInterest", "longName": "999029 - Disclosure - NON-CONTROLLING INTEREST", "shortName": "NON-CONTROLLING INTEREST", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R30": { "role": "http://portagebiotech.com/role/SubsequentEvents", "longName": "999030 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R31": { "role": "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies", "longName": "999031 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "31", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R32": { "role": "http://portagebiotech.com/role/SignificantAccountingPoliciesTables", "longName": "999032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R33": { "role": "http://portagebiotech.com/role/PrepaidExpensesOtherReceivablesAndOtherAssetsTables", "longName": "999033 - Disclosure - PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS (Tables)", "shortName": "PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfDetailedInformationAboutPrepaidExpensesAndOtherReceivableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfDetailedInformationAboutPrepaidExpensesAndOtherReceivableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R34": { "role": "http://portagebiotech.com/role/StablecoinTables", "longName": "999034 - Disclosure - STABLECOIN (Tables)", "shortName": "STABLECOIN (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfStablecoinTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfStablecoinExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:DisclosureOfStablecoinTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfStablecoinExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R35": { "role": "http://portagebiotech.com/role/DigitalAssetsTables", "longName": "999035 - Disclosure - DIGITAL ASSETS (Tables)", "shortName": "DIGITAL ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfDigitalAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfDigitalAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R36": { "role": "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsTables", "longName": "999036 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS (Tables)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:PropertyPlantAndEquipmentAndRightOfUseAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:PropertyPlantAndEquipmentAndRightOfUseAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R37": { "role": "http://portagebiotech.com/role/InvestmentInCompedicaTables", "longName": "999037 - Disclosure - INVESTMENT IN COMPEDICA (Tables)", "shortName": "INVESTMENT IN COMPEDICA (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfInvestmentBalanceTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfInvestmentBalanceTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R38": { "role": "http://portagebiotech.com/role/WarrantLiabilityTables", "longName": "999038 - Disclosure - WARRANT LIABILITY (Tables)", "shortName": "WARRANT LIABILITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfWarrantLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfWarrantLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R39": { "role": "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableTables", "longName": "999039 - Disclosure - PUT RIGHT LIABILITY AND TON PAYABLE (Tables)", "shortName": "PUT RIGHT LIABILITY AND TON PAYABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R40": { "role": "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesTables", "longName": "999040 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:AccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:AccountsPayableAndAccruedLiabilitiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:AccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:AccountsPayableAndAccruedLiabilitiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R41": { "role": "http://portagebiotech.com/role/LeaseLiabilityTables", "longName": "999041 - Disclosure - LEASE LIABILITY (Tables)", "shortName": "LEASE LIABILITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfLeaseLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfLeaseLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfLeaseLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfLeaseLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R42": { "role": "http://portagebiotech.com/role/IncomeTaxesTables", "longName": "999042 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfIncomeTaxesBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfIncomeTaxesBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R43": { "role": "http://portagebiotech.com/role/CapitalStockAndReservesTables", "longName": "999043 - Disclosure - CAPITAL STOCK AND RESERVES (Tables)", "shortName": "CAPITAL STOCK AND RESERVES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:CapitalStockAndReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:CapitalStockAndReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R44": { "role": "http://portagebiotech.com/role/StockOptionReserveTables", "longName": "999044 - Disclosure - STOCK OPTION RESERVE (Tables)", "shortName": "STOCK OPTION RESERVE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfTermsStockOptionReserveTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfTermsStockOptionReserveTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R45": { "role": "http://portagebiotech.com/role/LossPerShareTables", "longName": "999045 - Disclosure - LOSS PER SHARE (Tables)", "shortName": "LOSS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfEarningsPerShareTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfEarningsPerShareTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R46": { "role": "http://portagebiotech.com/role/RelatedPartyTransactionsTables", "longName": "999046 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfCompensationPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfCompensationPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R47": { "role": "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementTables", "longName": "999047 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R48": { "role": "http://portagebiotech.com/role/SegmentReportingTables", "longName": "999048 - Disclosure - SEGMENT REPORTING (Tables)", "shortName": "SEGMENT REPORTING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfSegmentReportingTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfSegmentReportingExplanatoryTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfSegmentReportingTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ptgef:DisclosureOfSegmentReportingExplanatoryTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R49": { "role": "http://portagebiotech.com/role/Non-controllingInterestTables", "longName": "999049 - Disclosure - NON-CONTROLLING INTEREST (Tables)", "shortName": "NON-CONTROLLING INTEREST (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfNoncontrollingInterestTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ScheduleOfNoncontrollingInterestTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R50": { "role": "http://portagebiotech.com/role/GoingConcernDetailsNarrative", "longName": "999050 - Disclosure - GOING CONCERN (Details Narrative)", "shortName": "GOING CONCERN (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfGoingConcernExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:TotalCurrentLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfGoingConcernExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R51": { "role": "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative", "longName": "999051 - Disclosure - BASIS OF PRESENTATION (Details Narrative)", "shortName": "BASIS OF PRESENTATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "From2025-04-012025-09-30_custom_SubsidiariesTwoMember", "name": "ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-012025-09-30_custom_SubsidiariesTwoMember", "name": "ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R52": { "role": "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails", "longName": "999052 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details )", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details )", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "From2025-04-012026-03-31_ifrs-full_WarrantsMember", "name": "ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023", "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_ifrs-full_WarrantsMember", "name": "ifrs-full:NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023", "ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R53": { "role": "http://portagebiotech.com/role/SignificantAccountingPoliciesDetailsNarrative", "longName": "999053 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:InvestmentProperty", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatory", "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:InvestmentProperty", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatory", "ptgef:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R54": { "role": "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails", "longName": "999054 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Details)", "shortName": "PREPAID EXPENSES AND OTHER RECEIVABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "ifrs-full:CurrentReceivablesFromSaleOfProperties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:DisclosureOfDetailedInformationAboutPrepaidExpensesAndOtherReceivableTableTextBlock", "ifrs-full:DisclosureOfOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "ifrs-full:CurrentReceivablesFromSaleOfProperties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:DisclosureOfDetailedInformationAboutPrepaidExpensesAndOtherReceivableTableTextBlock", "ifrs-full:DisclosureOfOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R55": { "role": "http://portagebiotech.com/role/PrepaidExpensesOtherReceivablesAndOtherAssetsDetailsNarrative", "longName": "999055 - Disclosure - PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS (Details Narrative)", "shortName": "PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:OtherAssetsLongTermPortion", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:OtherAssetsLongTermPortion", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfOtherAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R56": { "role": "http://portagebiotech.com/role/StablecoinDetails", "longName": "999056 - Disclosure - STABLECOIN (Details)", "shortName": "STABLECOIN (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "ptgef:Stablecoins", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:DisclosureOfStablecoinTableTextBlock", "ptgef:DisclosureOfStablecoinExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "ptgef:Stablecoins", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:DisclosureOfStablecoinTableTextBlock", "ptgef:DisclosureOfStablecoinExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R57": { "role": "http://portagebiotech.com/role/StablecoinDetails1", "longName": "999057 - Disclosure - STABLECOIN (Details 1)", "shortName": "STABLECOIN (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ContributionOfStablecoin", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_USDCMember", "name": "ptgef:ContributionOfStablecoin", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:DisclosureOfStablecoinPurchasesTableTextBlock", "ptgef:DisclosureOfStablecoinExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R58": { "role": "http://portagebiotech.com/role/DigitalAssetsDetails", "longName": "999058 - Disclosure - DIGITAL ASSETS (Details)", "shortName": "DIGITAL ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:ApproximateNumberOfTonTokensHeld", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfDigitalAssetsTableTextBlock", "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:ApproximateNumberOfTonTokensHeld", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfDigitalAssetsTableTextBlock", "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R59": { "role": "http://portagebiotech.com/role/DigitalAssetsDetails1", "longName": "999059 - Disclosure - DIGITAL ASSETS (Details 1)", "shortName": "DIGITAL ASSETS (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ContributionOfDigitalAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_TONMember", "name": "ptgef:ContributionOfDigitalAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfDigitalAssetsPurchasesTableTextBlock", "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R60": { "role": "http://portagebiotech.com/role/DigitalAssetsDetails2", "longName": "999060 - Disclosure - DIGITAL ASSETS (Details 2)", "shortName": "DIGITAL ASSETS (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:CapitalFutureMinimumPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:SeheduleOfTonTokensTableTextBlock", "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:CapitalFutureMinimumPaymentsRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:SeheduleOfTonTokensTableTextBlock", "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R61": { "role": "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails", "longName": "999061 - Disclosure - RECEIVABLES DIGITAL ASSETS (Details)", "shortName": "RECEIVABLES DIGITAL ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2025-04-012026-03-31_custom_USD1Member", "name": "ptgef:ContributionOfDigitalAssetAndStablecoinReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfReceivablesDigitalAssetsTableXextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_USD1Member", "name": "ptgef:ContributionOfDigitalAssetAndStablecoinReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfReceivablesDigitalAssetsTableXextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R62": { "role": "http://portagebiotech.com/role/DigitalAssetsDetailsNarrative", "longName": "999062 - Disclosure - DIGITAL ASSETS (Details Narrative)", "shortName": "DIGITAL ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:DigitalAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:DigitalAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DisclosureOfDigitalAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R63": { "role": "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails", "longName": "999063 - Disclosure - PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS (Details)", "shortName": "PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_GPUsMember", "name": "ifrs-full:AdditionsToRightofuseAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ptgef:PropertyPlantAndEquipmentAndRightOfUseAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R64": { "role": "http://portagebiotech.com/role/InvestmentInCompedicaDetails", "longName": "999064 - Disclosure - INVESTMENT IN COMPEDICA (Details)", "shortName": "INVESTMENT IN COMPEDICA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:InitialInvestmentInCompedica", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfInvestmentBalanceTableTextBlock", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:InitialInvestmentInCompedica", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfInvestmentBalanceTableTextBlock", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R65": { "role": "http://portagebiotech.com/role/InvestmentInCompedicaDetailsNarrative", "longName": "999065 - Disclosure - INVESTMENT IN COMPEDICA (Details Narrative)", "shortName": "INVESTMENT IN COMPEDICA (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2025-06-05", "name": "ifrs-full:ExpectedReimbursementOtherProvisions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-06-05", "name": "ifrs-full:ExpectedReimbursementOtherProvisions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R66": { "role": "http://portagebiotech.com/role/WarrantLiabilityDetails", "longName": "999066 - Disclosure - WARRANT LIABILITY (Details)", "shortName": "WARRANT LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ChangeInFairValueOfWarrantLiabilityAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfWarrantLiabilityTableTextBlock", "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ChangeInFairValueOfWarrantLiabilityAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfWarrantLiabilityTableTextBlock", "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R67": { "role": "http://portagebiotech.com/role/WarrantLiabilityDetails1", "longName": "999067 - Disclosure - WARRANT LIABILITY (Details 1)", "shortName": "WARRANT LIABILITY (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2025-08-292025-09-02", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-03_custom_SeriesBWarrantsMember", "name": "ptgef:ExercisePriceFairValue", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R68": { "role": "http://portagebiotech.com/role/WarrantLiabilityDetails2", "longName": "999068 - Disclosure - WARRANT LIABILITY (Details 2)", "shortName": "WARRANT LIABILITY (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2025-08-292025-09-02", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-03_custom_SeriesCWarrantsMember", "name": "ptgef:ExercisePriceFairValue", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:DisclosureOfFairValueMeasurementOfWarrantsExplanatory", "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R69": { "role": "http://portagebiotech.com/role/WarrantLiabilityDetails3", "longName": "999069 - Disclosure - WARRANT LIABILITY (Details 3)", "shortName": "WARRANT LIABILITY (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2025-08-292025-09-02", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": null }, "R70": { "role": "http://portagebiotech.com/role/WarrantLiabilityDetails4", "longName": "999070 - Disclosure - WARRANT LIABILITY (Details 4)", "shortName": "WARRANT LIABILITY (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "From2025-08-292025-09-02", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31_custom_PlacementAgentsWarrantsMember", "name": "ptgef:ExercisePriceFairValue", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:DisclosureOfFairValueMeasurementPlacementAgentExplanatory", "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R71": { "role": "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative", "longName": "999071 - Disclosure - WARRANT LIABILITY (Details Narrative)", "shortName": "WARRANT LIABILITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "AsOf2026-03-31_custom_SeiesBWarrantsMember", "name": "ptgef:FairValueOfWarrantPerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31_custom_SeiesBWarrantsMember", "name": "ptgef:FairValueOfWarrantPerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ptgef:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R72": { "role": "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "longName": "999072 - Disclosure - PUT RIGHT LIABILITY AND TON PAYABLE (Details)", "shortName": "PUT RIGHT LIABILITY AND TON PAYABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "AsOf2025-09-02", "name": "ifrs-full:ExercisePriceOfOutstandingShareOptions2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-09-02", "name": "ifrs-full:ExercisePriceOfOutstandingShareOptions2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R73": { "role": "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1", "longName": "999073 - Disclosure - PUT RIGHT LIABILITY AND TON PAYABLE (Details 1)", "shortName": "PUT RIGHT LIABILITY AND TON PAYABLE (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DecreaseThroughRightToConsiderationBecomingUnconditionalContractAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfPutRightLiabilityTableTextBlock", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:DecreaseThroughRightToConsiderationBecomingUnconditionalContractAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfPutRightLiabilityTableTextBlock", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R74": { "role": "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails2", "longName": "999074 - Disclosure - PUT RIGHT LIABILITY AND TON PAYABLE (Details 2)", "shortName": "PUT RIGHT LIABILITY AND TON PAYABLE (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ExerciseOfSideLetterPutRightPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfTonPayableTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:ExerciseOfSideLetterPutRightPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfTonPayableTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R75": { "role": "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative", "longName": "999075 - Disclosure - PUT RIGHT LIABILITY AND TON PAYABLE (Details Narrative)", "shortName": "PUT RIGHT LIABILITY AND TON PAYABLE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:TreasuryManagementAgreementDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:TreasuryManagementAgreementDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R76": { "role": "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails", "longName": "999076 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:AccountsPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:AccountsPayableAndAccruedLiabilitiesTableTextBlock", "ptgef:AccountsPayableAndAccruedLiabilitiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:AccountsPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:AccountsPayableAndAccruedLiabilitiesTableTextBlock", "ptgef:AccountsPayableAndAccruedLiabilitiesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R77": { "role": "http://portagebiotech.com/role/LeaseLiabilityDetails", "longName": "999077 - Disclosure - LEASE LIABILITY (Details)", "shortName": "LEASE LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:LeaseLiabilityFutureMinimumPaymentsDue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfLeaseLiabilityTableTextBlock", "ptgef:DisclosureOfLeaseLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:LeaseLiabilityFutureMinimumPaymentsDue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfLeaseLiabilityTableTextBlock", "ptgef:DisclosureOfLeaseLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R78": { "role": "http://portagebiotech.com/role/LeaseLiabilityDetailsNarrative", "longName": "999078 - Disclosure - LEASE LIABILITY (Details Narrative)", "shortName": "LEASE LIABILITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "AsOf2025-11-30", "name": "ptgef:Commencement", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DisclosureOfLeaseLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-11-30", "name": "ptgef:Commencement", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DisclosureOfLeaseLiabilityExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R79": { "role": "http://portagebiotech.com/role/BitgoPrimeLoanDetailsNarrative", "longName": "999079 - Disclosure - BITGO PRIME LOAN (Details Narrative)", "shortName": "BITGO PRIME LOAN (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "From2025-10-052025-10-07", "name": "ptgef:MasterLoanAgreementDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ptgef:DisclosureOfBitgoPrimeLoanExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-10-052025-10-07", "name": "ptgef:MasterLoanAgreementDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ptgef:DisclosureOfBitgoPrimeLoanExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R80": { "role": "http://portagebiotech.com/role/IncomeTaxesDetails", "longName": "999080 - Disclosure - INCOME TAXES (Details)", "shortName": "INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "From2024-04-012025-03-31", "name": "ptgef:AdjustmentsForCurrentTaxOfPriorPeriods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfIncomeTaxesBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-04-012025-03-31", "name": "ptgef:AdjustmentsForCurrentTaxOfPriorPeriods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfIncomeTaxesBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R81": { "role": "http://portagebiotech.com/role/IncomeTaxesDetails1", "longName": "999081 - Disclosure - INCOME TAXES (Details 1)", "shortName": "INCOME TAXES (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:IncomeLossOnOrdinaryActivitiesBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfReconciliationEffectiveIncomeTaxratesTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:IncomeLossOnOrdinaryActivitiesBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfReconciliationEffectiveIncomeTaxratesTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R82": { "role": "http://portagebiotech.com/role/IncomeTaxesDetails2", "longName": "999082 - Disclosure - INCOME TAXES (Details 2)", "shortName": "INCOME TAXES (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:DeferredTaxAssetsNetOperatingLossCarryforward", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfDeferredTaxAssetsTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:DeferredTaxAssetsNetOperatingLossCarryforward", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfDeferredTaxAssetsTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R83": { "role": "http://portagebiotech.com/role/IncomeTaxesDetailsNarrative", "longName": "999083 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R84": { "role": "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "longName": "999084 - Disclosure - CAPITAL STOCK AND RESERVES (Details )", "shortName": "CAPITAL STOCK AND RESERVES (Details )", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "From2025-08-292025-09-02", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": null }, "R85": { "role": "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "longName": "999085 - Disclosure - CAPITAL STOCK AND RESERVES (Details Narrative)", "shortName": "CAPITAL STOCK AND RESERVES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "AsOf2025-09-25", "name": "ptgef:SaleOfStock", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ptgef:CapitalStockAndReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-09-25", "name": "ptgef:SharesPrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ptgef:CapitalStockAndReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R86": { "role": "http://portagebiotech.com/role/StockOptionReserveDetails", "longName": "999086 - Disclosure - STOCK OPTION RESERVE (Details)", "shortName": "STOCK OPTION RESERVE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "ptgef:StockOptionReserve", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfTermsStockOptionReserveTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-04-012025-03-31", "name": "ptgef:CorrectionOfPriorPeriodOverstatedSharebasedCompensationsExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfTermsStockOptionReserveTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R87": { "role": "http://portagebiotech.com/role/StockOptionReserveDetails1", "longName": "999087 - Disclosure - STOCK OPTION RESERVE (Details 1)", "shortName": "STOCK OPTION RESERVE (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "ptgef:NumberOfOutstandingShareOption", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "ptgef:NumberOfOutstandingShareOption", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R88": { "role": "http://portagebiotech.com/role/StockOptionReserveDetails2", "longName": "999088 - Disclosure - STOCK OPTION RESERVE (Details 2)", "shortName": "STOCK OPTION RESERVE (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "From2025-08-292025-09-02", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "ptgef:DisclosureOPutRightLiabilityAndTonPayableExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_StockOptionGrantedMember", "name": "ptgef:DescriptionOfGrantPriceShareOptionsGranted", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfWeightedAverageAssumptionsTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R89": { "role": "http://portagebiotech.com/role/StockOptionReserveDetails3", "longName": "999089 - Disclosure - STOCK OPTION RESERVE (Details 3)", "shortName": "STOCK OPTION RESERVE (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R90": { "role": "http://portagebiotech.com/role/StockOptionReserveDetails4", "longName": "999090 - Disclosure - STOCK OPTION RESERVE (Details 4)", "shortName": "STOCK OPTION RESERVE (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "From2024-04-012025-03-31", "name": "ptgef:ShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfShareBasedCompensationStocksOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-04-012025-03-31", "name": "ptgef:ShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfShareBasedCompensationStocksOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R91": { "role": "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative", "longName": "999091 - Disclosure - STOCK OPTION RESERVE (Details Narrative)", "shortName": "STOCK OPTION RESERVE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "AsOf2025-07-27", "name": "ptgef:AuthorizedGrantOptionPurchaseShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-07-27", "name": "ptgef:AuthorizedGrantOptionPurchaseShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R92": { "role": "http://portagebiotech.com/role/LossPerShareDetails", "longName": "999092 - Disclosure - LOSS PER SHARE (Details)", "shortName": "LOSS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:WeightedAverageSharesOutstandingDiluted", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfEarningsPerShareTableTextBlock", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ptgef:WeightedAverageSharesOutstandingDiluted", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ptgef:ScheduleOfEarningsPerShareTableTextBlock", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R93": { "role": "http://portagebiotech.com/role/LossPerShareDetails1", "longName": "999093 - Disclosure - LOSS PER SHARE (Details 1)", "shortName": "LOSS PER SHARE (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "AsOf2026-03-31_ifrs-full_WarrantsMember", "name": "ptgef:AntidilutiveEffectOnLossPerShare", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfAntiDilutiveEffectTableTextBlock", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31_ifrs-full_WarrantsMember", "name": "ptgef:AntidilutiveEffectOnLossPerShare", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfAntiDilutiveEffectTableTextBlock", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R94": { "role": "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "longName": "999094 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "From2022-04-012023-03-31", "name": "ptgef:BudgetCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-04-012023-03-31", "name": "ptgef:BudgetCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R95": { "role": "http://portagebiotech.com/role/RelatedPartyTransactionsDetails", "longName": "999095 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:ShorttermEmployeeBenefitsExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfCompensationPayableTableTextBlock", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:ShorttermEmployeeBenefitsExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfCompensationPayableTableTextBlock", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R96": { "role": "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "longName": "999096 - Disclosure - RELATED PARTY TRANSACTIONS (Details 1)", "shortName": "RELATED PARTY TRANSACTIONS (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "AsOf2026-01-13", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ptgef:CapitalStockAndReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_MichaelTerpinMember_custom_DirectorCompensationMember", "name": "ifrs-full:FeeAndCommissionExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R97": { "role": "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3", "longName": "999097 - Disclosure - RELATED PARTY TRANSACTIONS (Details 3)", "shortName": "RELATED PARTY TRANSACTIONS (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:AdjustedWeightedAverageShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "ifrs-full:WeightedAverageShares", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_AlexanderPickettMember", "name": "ptgef:GrantDate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfOutstandingEquityAwardsTableTextBlock", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R98": { "role": "http://portagebiotech.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "999098 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "AsOf2025-09-25", "name": "ptgef:SaleOfStock", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ptgef:CapitalStockAndReservesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:Decentranet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R99": { "role": "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "longName": "999099 - Disclosure - - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details)", "shortName": "- FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31_custom_AmortizedCostMember", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock", "ptgef:DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R100": { "role": "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1", "longName": "999100 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details 1)", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:TonPayableToSettlePutRightsExercised", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31_custom_Level1Member", "name": "ptgef:DigitalAssetsAtFairValueTonLiquid", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:LiabilitiesMeasuredFairValueRecurringBasisTableTextBlock", "ptgef:DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R101": { "role": "http://portagebiotech.com/role/SegmentReportingDetails", "longName": "999101 - Disclosure - SEGMENT REPORTING (Details)", "shortName": "SEGMENT REPORTING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "From2025-04-01to2026-03-31", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-04-012026-03-31_custom_DigitalComputeMember", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfSegmentReportingTableTextBlock", "ptgef:DisclosureOfSegmentReportingExplanatoryTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } }, "R102": { "role": "http://portagebiotech.com/role/CapitalManagementDetailsNarrative", "longName": "999102 - Disclosure - CAPITAL MANAGEMENT (Details Narrative)", "shortName": "CAPITAL MANAGEMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:PayablesAndAccruedExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DisclosureOfCapitalManagementExplanatoryTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2026-03-31", "name": "ptgef:PayablesAndAccruedExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "ptgef:DisclosureOfCapitalManagementExplanatoryTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true, "unique": true } }, "R103": { "role": "http://portagebiotech.com/role/Non-controllingInterestDetails", "longName": "999103 - Disclosure - NON-CONTROLLING INTEREST (Details)", "shortName": "NON-CONTROLLING INTEREST (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "ifrs-full:NoncontrollingInterests", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-03-31_custom_SaugatuckMember", "name": "ifrs-full:NoncontrollingInterests", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ptgef:ScheduleOfNoncontrollingInterestTableTextBlock", "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20fa_071626.htm", "unique": true } } }, "tag": { "ptgef_ATMMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ATMMember", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ATM [Member]" } } }, "auth_ref": [] }, "ptgef_AccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccountsPayable", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts payable" } } }, "auth_ref": [] }, "ptgef_AccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccountsPayableAndAccruedLiabilities", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "AccountsPayableAndAccruedLiabilities" } } }, "auth_ref": [] }, "ptgef_AccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "ptgef_AccountsPayableAndAccruedLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccountsPayableAndAccruedLiabilitiesTextBlock", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" } } }, "auth_ref": [] }, "ptgef_AccountsPayableAndAccruedLiabilityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccountsPayableAndAccruedLiabilityNet", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Total accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "ptgef_AccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccountsReceivable", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accounts receivable" } } }, "auth_ref": [] }, "ptgef_AccruedAccountingAndAuditingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccruedAccountingAndAuditingFees", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued accounting and auditing fees" } } }, "auth_ref": [] }, "ptgef_AccruedBonusesAndOtherPayrollrelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccruedBonusesAndOtherPayrollrelatedExpenses", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued bonuses and other payroll-related expenses" } } }, "auth_ref": [] }, "ptgef_AccruedCRO": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccruedCRO", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued CRO" } } }, "auth_ref": [] }, "ptgef_AccruedClinicalAndRdServices": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccruedClinicalAndRdServices", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued clinical and R&D services" } } }, "auth_ref": [] }, "ptgef_AccruedOtherProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccruedOtherProfessionalFees", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued other professional fees" } } }, "auth_ref": [] }, "ptgef_AccumulatedDepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccumulatedDepreciationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "As of March 31, 2025", "periodEndLabel": "As of March 31, 2026", "label": "AccumulatedDepreciationPropertyPlantAndEquipment" } } }, "auth_ref": [] }, "ptgef_AccumulatedOtherComprehensiveIncomeLossMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AccumulatedOtherComprehensiveIncomeLossMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income Loss [Member]" } } }, "auth_ref": [] }, "ptgef_AdditionalRoundUpSharesIssuedForFractionalSharesInConnectionWith1for20ReverseStockSplit": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AdditionalRoundUpSharesIssuedForFractionalSharesInConnectionWith1for20ReverseStockSplit", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Additional round up shares issued for fractional shares in connection with 1-for-20 reverse share split" } } }, "auth_ref": [] }, "ptgef_AdditionalRoundUpSharesIssuedForFractionalSharesInConnectionWith1for20ReverseStockSplitShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AdditionalRoundUpSharesIssuedForFractionalSharesInConnectionWith1for20ReverseStockSplitShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Additional round up shares issued for fractional shares in connection with 1-for-20 reverse stock split, shares" } } }, "auth_ref": [] }, "ptgef_AdditionalSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AdditionalSharesIssued", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Additional shares issued" } } }, "auth_ref": [] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fixed asset additions" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r74", "r106" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AddressTypeDomain", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding, Diluted", "verboseLabel": "Weighted average number of ordinary shares used in calculating diluted earnings per share" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r26" ] }, "ptgef_AdjustmentsForCurrentTaxOfPriorPeriods": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AdjustmentsForCurrentTaxOfPriorPeriods", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Adjustments for current tax of prior periods" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 34.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Other assets", "label": "Adjustments for decrease (increase) in other assets" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]" } } }, "auth_ref": [ "r239" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 33.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaid expenses and other receivables", "label": "Adjustments for decrease (increase) in prepaid expenses" } }, "en": { "role": { "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]" } } }, "auth_ref": [ "r239" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 32.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable", "label": "Adjustments for decrease (increase) in trade accounts receivable" } } }, "auth_ref": [ "r237" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 36.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other current liabilities" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]" } } }, "auth_ref": [ "r239" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 35.0 } }, "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued liabilities", "label": "Accounts payable and accrued liabilitie" } } }, "auth_ref": [ "r237" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for non-cash items:" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StockOptionReserveDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation expense", "label": "Stock based compensation expense" } } }, "auth_ref": [ "r238" ] }, "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "U.S. federal net operating losses" } } }, "auth_ref": [ "r185", "r238" ] }, "ptgef_AggregateOfferingOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AggregateOfferingOrdinaryShares", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate offering ordinary shares" } } }, "auth_ref": [] }, "ptgef_AggregateProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AggregateProceeds", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "aggregate proceeds" } } }, "auth_ref": [] }, "ptgef_AlexanderPickettMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AlexanderPickettMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Alexander Pickett [Member]" } } }, "auth_ref": [] }, "ptgef_AlexanderPickettTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AlexanderPickettTwoMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Alexander Pickett Two [Member]" } } }, "auth_ref": [] }, "ptgef_AllanShawMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AllanShawMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Allan Shaw [Member]" } } }, "auth_ref": [] }, "ptgef_AllanShawThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AllanShawThreeMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Allan Shaw Three [Member]" } } }, "auth_ref": [] }, "ptgef_AllanShawTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AllanShawTwoMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Allan Shaw Two [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentDescription", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ptgef_AmortizedCostMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AmortizedCostMember", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Amortized Cost [Member]" } } }, "auth_ref": [] }, "ptgef_AndreaEParkMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AndreaEParkMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Andrea E Park [Member]" } } }, "auth_ref": [] }, "ptgef_AndreaEParkTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AndreaEParkTwoMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Andrea E Park Two [Member]" } } }, "auth_ref": [] }, "ptgef_AndreaParkMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AndreaParkMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Andrea Park [Member]" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AnnualInformationForm", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r219" ] }, "ptgef_AntidilutiveEffectOnLossPerShare": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AntidilutiveEffectOnLossPerShare", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Anti-dilutive effect on loss per share", "label": "AntidilutiveEffectOnLossPerShare" } } }, "auth_ref": [] }, "ptgef_ApproximateNumberOfTonTokensHeld": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ApproximateNumberOfTonTokensHeld", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Approximate number of TON Tokens held" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r66", "r67", "r68", "r96", "r99", "r141", "r142", "r163" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r219" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorFirmId", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r216", "r218", "r219" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorLocation", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r216", "r218", "r219" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorName", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r216", "r218", "r219" ] }, "ptgef_AuthorizedGrantOptionPurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "AuthorizedGrantOptionPurchaseShares", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Authorized grant option purchase shares" } } }, "auth_ref": [] }, "ptgef_BITCOINMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BITCOINMember", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "B I T C O I N [Member]" } } }, "auth_ref": [] }, "ptgef_BalanceApril12022PresplitShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BalanceApril12022PresplitShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Balance, April 1, 2022 (Pre-Split), shares" } } }, "auth_ref": [] }, "ptgef_BalanceAsOfApril1": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BalanceAsOfApril1", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetails" ], "lang": { "en-us": { "role": { "label": "Balance as of April 1" } } }, "auth_ref": [] }, "ptgef_BalanceOfPutRightLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BalanceOfPutRightLiability", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Balance as of April 1", "label": "BalanceOfPutRightLiability" } } }, "auth_ref": [] }, "ptgef_BalanceOfTonPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BalanceOfTonPayable", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Balance as of April 1", "label": "BalanceOfTonPayable" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Loss per share, Basic" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r24", "r25" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r39", "r71", "r76", "r81", "r110", "r187", "r188", "r241" ] }, "ptgef_BrianWileyMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BrianWileyMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Brian Wiley [Member]" } } }, "auth_ref": [] }, "ptgef_BrianWileyTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BrianWileyTwoMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Brian Wiley Two [Member]" } } }, "auth_ref": [] }, "ptgef_BrittanyKaiserMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BrittanyKaiserMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Brittany Kaiser [Member]" } } }, "auth_ref": [] }, "ptgef_BudgetCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "BudgetCosts", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Budget costs" } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "BusinessContactMember", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r218", "r219" ] }, "ptgef_CROAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CROAgreementMember", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "C R O Agreement [Member]" } } }, "auth_ref": [] }, "ptgef_CROMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CROMember", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "C R O [Member]" } } }, "auth_ref": [] }, "ptgef_CapitalExpenditures": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CapitalExpenditures", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Capital expenditures" } } }, "auth_ref": [] }, "ptgef_CapitalExpendituresIncludedInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CapitalExpendituresIncludedInAccountsPayable", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Capital expenditures included in accounts payable" } } }, "auth_ref": [] }, "ptgef_CapitalFutureMinimumPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CapitalFutureMinimumPaymentsRemainderOfFiscalYear", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "Fiscal 2027" } } }, "auth_ref": [] }, "ptgef_CapitalFutureMinimumPaymentsRemainderOfSecondYear": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CapitalFutureMinimumPaymentsRemainderOfSecondYear", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "Fiscal 2028" } } }, "auth_ref": [] }, "ptgef_CapitalFutureMinimumPaymentsRemainderOfThirdYear": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CapitalFutureMinimumPaymentsRemainderOfThirdYear", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "Fiscal 2029" } } }, "auth_ref": [] }, "ptgef_CapitalFutureMinimumPaymentsRemainderOfTotalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CapitalFutureMinimumPaymentsRemainderOfTotalYear", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "total" } } }, "auth_ref": [] }, "ptgef_CapitalStockAndReservesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CapitalStockAndReservesTextBlock", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReserves" ], "lang": { "en-us": { "role": { "label": "CAPITAL STOCK AND RESERVES" } } }, "auth_ref": [] }, "ifrs-full_Cash": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Cash", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } } }, "auth_ref": [ "r240" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r40", "r60", "r111", "r158" ] }, "ptgef_CashCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CashCashEquivalents", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "cash, cash equivalents" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations." } } }, "auth_ref": [ "r38", "r41" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) provided by investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations." } } }, "auth_ref": [ "r38", "r41" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Cash flows from (used in) operating activities" } } }, "auth_ref": [ "r38", "r41" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "ptgef_CashPaidForInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CashPaidForInterest", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest" } } }, "auth_ref": [] }, "ptgef_CashPaidForInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CashPaidForInvestmentInCompedica", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash paid for investment in Compedica", "label": "CashPaidForInvestmentInCompedica" } } }, "auth_ref": [] }, "ptgef_CashRestrictedForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CashRestrictedForUse", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash restricted for use" } } }, "auth_ref": [] }, "ptgef_CashUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CashUsedInOperatingActivities", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash Used In Operating Activities" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfFinancialAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfFinancialAssetsAbstract", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfFinancialLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfFinancialLiabilitiesAbstract", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative", "http://portagebiotech.com/role/LossPerShareDetails1", "http://portagebiotech.com/role/Non-controllingInterestDetails", "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3", "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r16", "r122" ] }, "ifrs-full_CategoriesOfRelatedPartiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesDomain", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative", "http://portagebiotech.com/role/LossPerShareDetails1", "http://portagebiotech.com/role/Non-controllingInterestDetails", "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3", "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r16", "r122" ] }, "ptgef_ChangeInFairValueOfDeferredPurchasePricePayableTarusAndDeferredObligationIoxMilestone": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOfDeferredPurchasePricePayableTarusAndDeferredObligationIoxMilestone", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 }, "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Change in fair value of deferred purchase price payable - Tarus and deferred obligation - iOx milestone", "negatedLabel": "Change in fair value of deferred purchase price payable - Tarus and deferred obligation - iOx milestone" } } }, "auth_ref": [] }, "ptgef_ChangeInFairValueOfDigitalAssetsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOfDigitalAssetsReceivable", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Change in fair value of digital assets receivable" } } }, "auth_ref": [] }, "ptgef_ChangeInFairValueOfInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOfInvestmentInCompedica", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetails" ], "lang": { "en-us": { "role": { "label": "Change in fair value of investment in Compedica" } } }, "auth_ref": [] }, "ptgef_ChangeInFairValueOfPutRightsNetOfRedemptions": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOfPutRightsNetOfRedemptions", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 4.0 }, "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of put rights, net of redemptions", "label": "Change in fair value of put rights, net of redemptions" } } }, "auth_ref": [] }, "ptgef_ChangeInFairValueOfTonPayableToSettlePutRightsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOfTonPayableToSettlePutRightsExercised", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 20.0 }, "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails2", "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Change in fair value of TON payable to settle put rights exercised", "negatedLabel": "Change in fair value of TON payable to settle put rights exercised" } } }, "auth_ref": [] }, "ptgef_ChangeInFairValueOfWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOfWarrantLiability", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in fair value of warrant liability", "label": "ChangeInFairValueOfWarrantLiability" } } }, "auth_ref": [] }, "ptgef_ChangeInFairValueOfWarrantLiabilityAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOfWarrantLiabilityAmount", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Change in fair value of warrant liability, amount" } } }, "auth_ref": [] }, "ptgef_ChangeInFairValueOnInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ChangeInFairValueOnInvestmentInCompedica", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Change in fair value on the investment in Compedica" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ptgef_ClassBWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ClassBWarrantsMember", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Class B Warrants [Member]" } } }, "auth_ref": [] }, "ptgef_ClassCWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ClassCWarrantsMember", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Class C Warrants [Member]" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r87", "r88", "r89", "r90", "r137", "r138" ] }, "ifrs-full_ClassesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfFinancialInstrumentsDomain", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r87", "r88", "r89", "r90", "r137", "r138" ] }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets and goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r234" ] }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsAndGoodwillDomain", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r234" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r8", "r118" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentDomain", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used." } } }, "auth_ref": [ "r8", "r118" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4", "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r109", "r145", "r170" ] }, "ifrs-full_ClassesOfShareCapitalDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfShareCapitalDomain", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4", "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r109", "r145", "r170" ] }, "ptgef_Commencement": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Commencement", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Commencement" } } }, "auth_ref": [] }, "ptgef_CommitmentFeeUnderCommittedPurchaseAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CommitmentFeeUnderCommittedPurchaseAgreement", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 }, "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Commitment fee under Committed Purchase Agreement", "label": "Commitment fee under Committed Purchase Agreement" } } }, "auth_ref": [] }, "ptgef_CommitmentsAndContingentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CommitmentsAndContingentLiabilities", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingent Liabilities (Note 20)" } } }, "auth_ref": [] }, "ifrs-full_CompensationFromThirdPartiesForItemsOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CompensationFromThirdPartiesForItemsOfPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Total compensation" } } }, "auth_ref": [ "r9" ] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r153" ] }, "ifrs-full_ComponentsOfEquityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityDomain", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r153" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss for period", "label": "Comprehensive income" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r43", "r45", "r57", "r124", "r132", "r150", "r172", "r186" ] }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Comprehensive loss attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-controlling interest", "label": "Comprehensive income, attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } } }, "auth_ref": [ "r150", "r175" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Owners of the Company", "label": "Comprehensive income, attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r150", "r176" ] }, "ifrs-full_ConsolidatedStructuredEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ConsolidatedStructuredEntitiesAxis", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated structured entities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r65" ] }, "ifrs-full_ConsolidatedStructuredEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ConsolidatedStructuredEntitiesDomain", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Consolidated structured entities' axis if no other member is used." } } }, "auth_ref": [ "r65" ] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContactPersonnelName", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "ptgef_ContractualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ContractualPayments", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Contractual payments" } } }, "auth_ref": [] }, "ptgef_ContributionOfDigitalAssetAndStablecoinReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ContributionOfDigitalAssetAndStablecoinReceivables", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Contribution of digital asset and stablecoin receivables" } } }, "auth_ref": [] }, "ptgef_ContributionOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ContributionOfDigitalAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Contribution of digital assets" } } }, "auth_ref": [] }, "ptgef_ContributionOfDigitalAssetsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ContributionOfDigitalAssetsReceivable", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Contribution of digital assets receivable" } } }, "auth_ref": [] }, "ptgef_ContributionOfStablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ContributionOfStablecoin", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Contribution of stablecoin", "verboseLabel": "Contribution of Stablecoin" } } }, "auth_ref": [] }, "ptgef_ContributionOfStablecoinReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ContributionOfStablecoinReceivable", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Contribution of stablecoin receivable" } } }, "auth_ref": [] }, "ptgef_CorrectionOfPriorPeriodOverstatedSharebasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CorrectionOfPriorPeriodOverstatedSharebasedCompensationExpense", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Correction of prior period overstated share-based compensation expense" } } }, "auth_ref": [] }, "ptgef_CorrectionOfPriorPeriodOverstatedSharebasedCompensationsExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CorrectionOfPriorPeriodOverstatedSharebasedCompensationsExpense", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Correction of prior period overstated share-based compensation expense", "label": "CorrectionOfPriorPeriodOverstatedSharebasedCompensationsExpense" } } }, "auth_ref": [] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r92" ] }, "ifrs-full_CounterpartiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CounterpartiesDomain", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r92" ] }, "ptgef_CountryOfBritishVirginIslandsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CountryOfBritishVirginIslandsMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Country Of British Virgin Islands [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CurrentAdvancesToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAdvancesToSuppliers", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid insurance" } }, "en": { "role": { "documentation": "The amount of current advances made to suppliers before goods or services are received." } } }, "auth_ref": [ "r244" ] }, "ptgef_CurrentAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CurrentAsset", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CapitalManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Current assets", "label": "CurrentAsset" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r53", "r165", "r186" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentInterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentInterestReceivable", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of stablecoin receivable" } }, "en": { "role": { "documentation": "The amount of current interest receivable. [Refer: Interest receivable]" } } }, "auth_ref": [ "r244" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Lease liability - current" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r73" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r55", "r166", "r186" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Other prepaid expenses" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r244" ] }, "ifrs-full_CurrentReceivablesFromSaleOfProperties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentReceivablesFromSaleOfProperties", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid clinical research costs" } }, "en": { "role": { "documentation": "The amount of current receivables from sale of properties. [Refer: Receivables from sale of properties]" } } }, "auth_ref": [ "r248" ] }, "ifrs-full_CurrentRestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentRestrictedCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "label": "Current restricted cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]" } } }, "auth_ref": [ "r247" ] }, "ifrs-full_CurrentTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxExpenseIncome", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Total current tax benefit" } } }, "auth_ref": [ "r180", "r196" ] }, "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current tax:" } } }, "auth_ref": [] }, "ptgef_CurrentTaxOnProfitsForYear": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "CurrentTaxOnProfitsForYear", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current tax on profits for the year" } } }, "auth_ref": [] }, "ptgef_Decentranet": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Decentranet", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "DecentraNet" } } }, "auth_ref": [] }, "ptgef_DecreaseIncreaseInDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DecreaseIncreaseInDeferredTaxAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Decrease (increase) in deferred tax assets" } } }, "auth_ref": [] }, "ifrs-full_DecreaseThroughRightToConsiderationBecomingUnconditionalContractAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DecreaseThroughRightToConsiderationBecomingUnconditionalContractAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Put right recognition at contract inception" } }, "en": { "role": { "documentation": "The decrease in contract assets resulting from the right to consideration becoming unconditional. [Refer: Contract assets]" } } }, "auth_ref": [ "r189" ] }, "ptgef_DeferredFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DeferredFinancingCosts", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred financing costs", "label": "DeferredFinancingCosts" } } }, "auth_ref": [] }, "ptgef_DeferredTaxAssetNotRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DeferredTaxAssetNotRecognized", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred tax asset not recognized", "label": "DeferredTaxAssetNotRecognized" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r4", "r115", "r160", "r164" ] }, "ptgef_DeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DeferredTaxAssetsAbstract", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets:" } } }, "auth_ref": [] }, "ptgef_DeferredTaxAssetsNetOperatingLossCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DeferredTaxAssetsNetOperatingLossCarryforward", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/IncomeTaxesDetails2": { "parentTag": "ifrs-full_NetDeferredTaxAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Tax loss" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxExpenseIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxExpenseIncomeAbstract", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred income tax:" } } }, "auth_ref": [] }, "ifrs-full_DefinedBenefitPlansAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DefinedBenefitPlansAxis", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "label": "Defined benefit plans [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r11", "r120" ] }, "ifrs-full_DefinedBenefitPlansDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DefinedBenefitPlansDomain", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used." } } }, "auth_ref": [ "r11", "r120" ] }, "ptgef_DelawareMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DelawareMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Delaware [Member]" } } }, "auth_ref": [] }, "ptgef_Deposit": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Deposit", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deposit" } } }, "auth_ref": [] }, "ifrs-full_DepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 25.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest (expense) income, net", "verboseLabel": "Depreciation and amortization expense", "label": "Depreciation and amortisation expense" } }, "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } } }, "auth_ref": [ "r61", "r94", "r101", "r149", "r179", "r199" ] }, "ptgef_DepreciationAndAmortizations": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DepreciationAndAmortizations", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 31.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization" } } }, "auth_ref": [] }, "ifrs-full_DepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DepreciationExpense", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization expense" } } }, "auth_ref": [ "r244" ] }, "ptgef_DerecognitionOfDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DerecognitionOfDeferredTaxAssets", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Derecognition of deferred tax assets" } } }, "auth_ref": [] }, "ptgef_DerecognitionOfInvestmentInPublicCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DerecognitionOfInvestmentInPublicCompany", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Derecognition of investment in public company" } } }, "auth_ref": [] }, "ptgef_DescriptionOfAccountingPolicyFoStablecoinExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyFoStablecoinExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Stablecoin", "label": "DescriptionOfAccountingPolicyFoStablecoinExplanatory" } } }, "auth_ref": [] }, "ptgef_DescriptionOfAccountingPolicyForAccountsReceivableExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForAccountsReceivableExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable" } } }, "auth_ref": [] }, "ptgef_DescriptionOfAccountingPolicyForAdoptionOfNewStandardsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForAdoptionOfNewStandardsExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements" } } }, "auth_ref": [] }, "ptgef_DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForCashAndCashEquivalentsExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, and Restricted Cash" } } }, "auth_ref": [] }, "ptgef_DescriptionOfAccountingPolicyForContingentLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForContingentLiabilitiesExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Contingent Liability" } } }, "auth_ref": [] }, "ptgef_DescriptionOfAccountingPolicyForDigitalAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForDigitalAssetsExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Digital Assets", "label": "DescriptionOfAccountingPolicyForDigitalAssetsExplanatory" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss Per Share" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for earnings per share." } } }, "auth_ref": [ "r245" ] }, "ptgef_DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForExpectedCreditLossesExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Expected Credit Losses" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Determination of Fair Value" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial Instruments" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Financial Assets and Intangible Assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r245" ] }, "ptgef_DescriptionOfAccountingPolicyForImpairmentOfIndefiniteLifeIntangibleAssetsOtherThanGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForImpairmentOfIndefiniteLifeIntangibleAssetsOtherThanGoodwillExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Property, Plant, and Equipment and Indefinite Life Intangible Assets other than Goodwill" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for income tax." } } }, "auth_ref": [ "r245" ] }, "ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForInvestmentInAssociates", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investment in Associate" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for investments in associates. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r245" ] }, "ptgef_DescriptionOfAccountingPolicyForInvestmentInPrivateCompaniesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForInvestmentInPrivateCompaniesExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investment in Public Company" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development Expenses" } } }, "auth_ref": [ "r245" ] }, "ptgef_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue from Contracts with Customers" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share-based Payments" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "http://portagebiotech.com/role/StockOptionReserveDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "verboseLabel": "Expected ALP volatility" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r82" ] }, "ptgef_DescriptionOfGrantPriceShareOptionsGranted": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfGrantPriceShareOptionsGranted", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails2" ], "lang": { "en-us": { "role": { "label": "Grant price" } } }, "auth_ref": [] }, "ptgef_DescriptionOfPolicyForPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DescriptionOfPolicyForPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "http://portagebiotech.com/role/StockOptionReserveDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r82" ] }, "ptgef_DgitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DgitalAssets", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dgital assets" } } }, "auth_ref": [] }, "ptgef_DigitalAssetPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetPurchases", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Digital asset purchases" } } }, "auth_ref": [] }, "ptgef_DigitalAssetValueAsOfApril1": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetValueAsOfApril1", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1", "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails", "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Digital asset value as of April 1" } } }, "auth_ref": [] }, "ptgef_DigitalAssetValueAsOfMarch31": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetValueAsOfMarch31", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Digital asset value as of March 31" } } }, "auth_ref": [] }, "ptgef_DigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssets", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Digital assets" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsAtFairValueTonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsAtFairValueTonCurrent", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Digital assets at fair value, TON, current" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsAtFairValueTonLiquid": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsAtFairValueTonLiquid", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "label": "Digital assets at fair value, TON liquid" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsAtFairValueTonLocked": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsAtFairValueTonLocked", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "label": "Digital assets at fair value, TON locked" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsAtFairValueTonNetOfCurrentPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsAtFairValueTonNetOfCurrentPortion", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Digital assets at fair value, TON, net of current portion" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsExchanged": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsExchanged", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Digital assets exchanged" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsFairValueInThousands": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsFairValueInThousands", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Digital assets, fair value (in thousands)" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsSold", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Digital assets sold" } } }, "auth_ref": [] }, "ptgef_DigitalAssetsTransacted": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalAssetsTransacted", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Digital assets transacted" } } }, "auth_ref": [] }, "ptgef_DigitalComputeMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DigitalComputeMember", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Digital Compute [Member]" } } }, "auth_ref": [] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Loss per share, Diluted" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r24", "r25" ] }, "ptgef_DirectorCompensationMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DirectorCompensationMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Director Compensation [Member]" } } }, "auth_ref": [] }, "ptgef_DisclosureAccountsPayableAndAccruedLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureAccountsPayableAndAccruedLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Accounts Payable And Accrued Liabilities" } } }, "auth_ref": [] }, "ptgef_DisclosureBitgoPrimeLoanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureBitgoPrimeLoanAbstract", "lang": { "en-us": { "role": { "label": "Bitgo Prime Loan" } } }, "auth_ref": [] }, "ptgef_DisclosureCapitalManagementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureCapitalManagementAbstract", "lang": { "en-us": { "role": { "label": "Capital Management" } } }, "auth_ref": [] }, "ptgef_DisclosureCapitalStockAndReservesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureCapitalStockAndReservesAbstract", "lang": { "en-us": { "role": { "label": "Capital Stock And Reserves" } } }, "auth_ref": [] }, "ptgef_DisclosureDigitalAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureDigitalAssetsAbstract", "lang": { "en-us": { "role": { "label": "Digital Assets" } } }, "auth_ref": [] }, "ptgef_DisclosureFinancialInstrumentsAndRiskManagementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureFinancialInstrumentsAndRiskManagementAbstract", "lang": { "en-us": { "role": { "label": "Financial Instruments And Risk Management" } } }, "auth_ref": [] }, "ptgef_DisclosureLeaseLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureLeaseLiabilityAbstract", "lang": { "en-us": { "role": { "label": "Lease Liability" } } }, "auth_ref": [] }, "ptgef_DisclosureNatureOfOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureNatureOfOperationsAbstract", "lang": { "en-us": { "role": { "label": "Nature Of Operations" } } }, "auth_ref": [] }, "ptgef_DisclosureOPutRightLiabilityAndTonPayableExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOPutRightLiabilityAndTonPayableExplanatory", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayable" ], "lang": { "en-us": { "role": { "label": "PUT RIGHT LIABILITY AND TON PAYABLE" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAuditorsRemunerationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfAuditorsRemunerationExplanatory", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Compensation" } }, "en": { "role": { "documentation": "The disclosure of compensation to the entity's auditors." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBasisOfConsolidationExplanatory", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "BASIS OF PRESENTATION" } }, "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } } }, "auth_ref": [ "r242" ] }, "ptgef_DisclosureOfBitgoPrimeLoanExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfBitgoPrimeLoanExplanatory", "presentation": [ "http://portagebiotech.com/role/BitgoPrimeLoan" ], "lang": { "en-us": { "role": { "label": "BITGO PRIME LOAN" } } }, "auth_ref": [] }, "ptgef_DisclosureOfCapitalManagementExplanatoryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfCapitalManagementExplanatoryTextBlock", "presentation": [ "http://portagebiotech.com/role/CapitalManagement" ], "lang": { "en-us": { "role": { "label": "CAPITAL MANAGEMENT" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilities" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENT LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Classes of contingent liabilities [domain]]" } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfDefinedBenefitPlansTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDefinedBenefitPlansTable", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of defined benefit plans [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to defined benefit plans." } } }, "auth_ref": [ "r11", "r120" ] }, "ptgef_DisclosureOfDetailedInformationAboutPrepaidExpensesAndOtherReceivableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfDetailedInformationAboutPrepaidExpensesAndOtherReceivableTableTextBlock", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesOtherReceivablesAndOtherAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of prepaid expenses and other receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property, plant, and equipment, equipment deposits, and right-of-use assets" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r8", "r118" ] }, "ptgef_DisclosureOfDigitalAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfDigitalAssetsExplanatory", "presentation": [ "http://portagebiotech.com/role/DigitalAssets" ], "lang": { "en-us": { "role": { "label": "DIGITAL ASSETS" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://portagebiotech.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r0" ] }, "ifrs-full_DisclosureOfFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementExplanatory", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of inputs associated with calculating the fair value" } }, "en": { "role": { "documentation": "The entire disclosure for fair value measurement." } } }, "auth_ref": [ "r70" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://portagebiotech.com/role/StockOptionReserveDetails2" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r69", "r143" ] }, "ptgef_DisclosureOfFairValueMeasurementOfWarrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfFairValueMeasurementOfWarrantsExplanatory", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of fair value" } } }, "auth_ref": [] }, "ptgef_DisclosureOfFairValueMeasurementPlacementAgentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfFairValueMeasurementPlacementAgentExplanatory", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of 2026 placement agent warrants" } } }, "auth_ref": [] }, "ptgef_DisclosureOfFairValueOfPlacementAgentWarrantsMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfFairValueOfPlacementAgentWarrantsMeasurementExplanatory", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Placement agent warrants" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets that are either past due or impaired [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial assets that are either past due or impaired." } } }, "auth_ref": [ "r148" ] }, "ptgef_DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfFinancialInstrumentsAndRiskManagementExplanatory", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagement" ], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsTable", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } } }, "auth_ref": [ "r86", "r88", "r91", "r136" ] }, "ifrs-full_DisclosureOfGoingConcernExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfGoingConcernExplanatory", "presentation": [ "http://portagebiotech.com/role/GoingConcern" ], "lang": { "en-us": { "role": { "label": "GOING CONCERN" } }, "en": { "role": { "documentation": "The disclosure of the entity's ability to continue as a going concern." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://portagebiotech.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of anti-dilutive effect on loss per share" } }, "en": { "role": { "documentation": "The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share because they are antidilutive for the period(s) presented." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails", "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]" } }, "en": { "role": { "documentation": "Schedule disclosing instruments with potential future dilutive effect not included in calculation of diluted earnings per share." } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsMaterialToEntityTable", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of intangible assets material to entity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to intangible assets that are material to the entity." } } }, "auth_ref": [ "r31", "r126" ] }, "ifrs-full_DisclosureOfInterestsInOtherEntitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInterestsInOtherEntitiesExplanatory", "presentation": [ "http://portagebiotech.com/role/Non-controllingInterest" ], "lang": { "en-us": { "role": { "label": "NON-CONTROLLING INTEREST" } }, "en": { "role": { "documentation": "The entire disclosure for interests in other entities." } } }, "auth_ref": [ "r47" ] }, "ifrs-full_DisclosureOfInvestmentPropertyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfInvestmentPropertyExplanatory", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedica" ], "lang": { "en-us": { "role": { "label": "INVESTMENT IN COMPEDICA" } }, "en": { "role": { "documentation": "The entire disclosure for investment property." } } }, "auth_ref": [ "r36" ] }, "ptgef_DisclosureOfLeaseLiabilityExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfLeaseLiabilityExplanatory", "presentation": [ "http://portagebiotech.com/role/LeaseLiability" ], "lang": { "en-us": { "role": { "label": "LEASE LIABILITY" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveTables" ], "lang": { "en-us": { "role": { "label": "Schedule of weighted average exercise price and the remaining contractual life" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r81" ] }, "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOffsettingOfFinancialAssetsTable", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of offsetting of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the offsetting of financial assets." } } }, "auth_ref": [ "r84" ] }, "ifrs-full_DisclosureOfOtherAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOtherAssetsExplanatory", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesOtherReceivablesAndOtherAssets" ], "lang": { "en-us": { "role": { "label": "PREPAID EXPENSES, OTHER RECEIVABLES, AND OTHER ASSETS" } }, "en": { "role": { "documentation": "The disclosure of other assets. [Refer: Other assets]" } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r8", "r118" ] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutFinancialInstrumentsThatHaveYetToTransitionToAlternativeBenchmarkRateTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutFinancialInstrumentsThatHaveYetToTransitionToAlternativeBenchmarkRateTable", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about financial instruments that have yet to transition to alternative benchmark rate [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the quantitative information about financial instruments that have yet to transition to alternative benchmark rate." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill." } } }, "auth_ref": [ "r234" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r17" ] }, "ptgef_DisclosureOfSegmentReportingExplanatoryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfSegmentReportingExplanatoryTextBlock", "presentation": [ "http://portagebiotech.com/role/SegmentReporting" ], "lang": { "en-us": { "role": { "label": "SEGMENT REPORTING" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://portagebiotech.com/role/StockOptionReserve" ], "lang": { "en-us": { "role": { "label": "STOCK OPTION RESERVE" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r77" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } } }, "auth_ref": [ "r20", "r22", "r63", "r139" ] }, "ptgef_DisclosureOfStablecoinExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfStablecoinExplanatory", "presentation": [ "http://portagebiotech.com/role/Stablecoin" ], "lang": { "en-us": { "role": { "label": "STABLECOIN" } } }, "auth_ref": [] }, "ptgef_DisclosureOfStablecoinPurchasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfStablecoinPurchasesTableTextBlock", "presentation": [ "http://portagebiotech.com/role/StablecoinTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stablecoin purchases" } } }, "auth_ref": [] }, "ptgef_DisclosureOfStablecoinTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfStablecoinTableTextBlock", "presentation": [ "http://portagebiotech.com/role/StablecoinTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stablecoin" } } }, "auth_ref": [] }, "ptgef_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails1", "http://portagebiotech.com/role/Non-controllingInterestDetails", "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3", "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r16", "r122" ] }, "ptgef_DisclosureOfWarrantLiabilityExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureOfWarrantLiabilityExplanatory", "presentation": [ "http://portagebiotech.com/role/WarrantLiability" ], "lang": { "en-us": { "role": { "label": "WARRANT LIABILITY" } } }, "auth_ref": [] }, "ptgef_DisclosurePropertyPlantAndEquipmentAndRightofuseAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosurePropertyPlantAndEquipmentAndRightofuseAssetsAbstract", "lang": { "en-us": { "role": { "label": "Property Plant And Equipment And Right-of-use Assets" } } }, "auth_ref": [] }, "ptgef_DisclosurePutRightLiabilityAndTonPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosurePutRightLiabilityAndTonPayableAbstract", "lang": { "en-us": { "role": { "label": "Put Right Liability And Ton Payable" } } }, "auth_ref": [] }, "ptgef_DisclosureSegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureSegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting" } } }, "auth_ref": [] }, "ptgef_DisclosureSignificantAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureSignificantAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "auth_ref": [] }, "ptgef_DisclosureStablecoinAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureStablecoinAbstract", "lang": { "en-us": { "role": { "verboseLabel": "Stablecoin" } } }, "auth_ref": [] }, "ptgef_DisclosureWarrantLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "DisclosureWarrantLiabilityAbstract", "lang": { "en-us": { "role": { "label": "Warrant Liability" } } }, "auth_ref": [] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fixed asset disposals" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r6", "r116" ] }, "ifrs-full_DividendsReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsReceived", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 28.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Revenues received in TON tokens", "label": "Dividends received" } }, "en": { "role": { "documentation": "The amount of dividends received." } } }, "auth_ref": [ "r52" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAccountingStandard", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r218" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r216", "r218", "r219" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r216", "r218", "r219", "r221" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodStartDate", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r217" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentRegistrationStatement", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r205" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r218" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyReport", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r218" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r220" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r208" ] }, "ifrs-full_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EarningsPerShareAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Loss per share" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://portagebiotech.com/role/LossPerShare" ], "lang": { "en-us": { "role": { "label": "LOSS PER SHARE" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r24" ] }, "ptgef_EffectOfTaxRatesInOtherCountries": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "EffectOfTaxRatesInOtherCountries", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Effect of tax rates in other countries" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine3", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesLineItems", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesTable", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r207" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r211" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r207" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r207" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityExTransitionPeriod", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r225" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r207" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r222" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPrimarySicNumber", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r219" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r207" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r207" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r207" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r207" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r223" ] }, "ptgef_EnzoVillaniMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "EnzoVillaniMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Enzo Villani [Member]" } } }, "auth_ref": [] }, "ptgef_EquipmentDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "EquipmentDeposit", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Equipment deposits", "label": "EquipmentDeposit" } } }, "auth_ref": [] }, "ptgef_EquipmentDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "EquipmentDeposits", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equipment deposits" } } }, "auth_ref": [] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit", "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r42", "r44", "r66", "r67", "r68", "r123", "r131", "r141", "r142", "r147", "r163", "r168" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Equity" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r163" ] }, "ifrs-full_EquityAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilitiesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity attributable to owners of the Company", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent [member]" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r153" ] }, "ptgef_ExchangeOfBitcoinForTonTokens": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExchangeOfBitcoinForTonTokens", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exchange of Bitcoin for TON tokens" } } }, "auth_ref": [] }, "ptgef_ExchangeOfStimunityConvertibleNoteForStimunitySharesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExchangeOfStimunityConvertibleNoteForStimunitySharesAtFairValue", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exchange of Stimunity Convertible Note for Stimunity shares at fair value" } } }, "auth_ref": [] }, "ptgef_ExecutiveOfficerCompensationMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExecutiveOfficerCompensationMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Executive Officer Compensation [Member]" } } }, "auth_ref": [] }, "ptgef_ExerciseOfPrefundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExerciseOfPrefundedWarrants", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Exercise of pre-funded warrants" } } }, "auth_ref": [] }, "ptgef_ExerciseOfPrefundedWarrantsShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExerciseOfPrefundedWarrantsShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Exercise of pre-funded warrants , shares" } } }, "auth_ref": [] }, "ptgef_ExerciseOfPutRights": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExerciseOfPutRights", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exercise of put rights" } } }, "auth_ref": [] }, "ptgef_ExerciseOfSideLetterPutRightPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExerciseOfSideLetterPutRightPayable", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise of side letter put right", "label": "ExerciseOfSideLetterPutRightPayable" } } }, "auth_ref": [] }, "ptgef_ExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExercisePrice", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [] }, "ptgef_ExercisePriceFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExercisePriceFairValue", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4" ], "lang": { "en-us": { "role": { "label": "Exercise price" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExercisePriceOfOutstandingShareOptions2019", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails" ], "lang": { "en-us": { "role": { "label": "Alp shares and ton correlation factor" } }, "en": { "role": { "documentation": "The exercise price of outstanding share options." } } }, "auth_ref": [ "r81" ] }, "ptgef_ExercisePrices": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExercisePrices", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Exercise Prices" } } }, "auth_ref": [] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "http://portagebiotech.com/role/StockOptionReserveDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4" ], "lang": { "en-us": { "role": { "label": "Expected dividend", "verboseLabel": "ALP dividend yield", "terseLabel": "Expected dividend as percentage, share options granted" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r82" ] }, "ifrs-full_ExpectedReimbursementOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExpectedReimbursementOtherProvisions", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "reimbursement of expenses" } }, "en": { "role": { "documentation": "The amount expected to be reimbursed by another party on expenditures to settle other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r30", "r125" ] }, "ptgef_ExpensesSettledUsingStablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExpensesSettledUsingStablecoin", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 27.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Expenses settled using stablecoin" } } }, "auth_ref": [] }, "ptgef_ExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExpirationDate", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Extension", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "ptgef_ExternalDebtProceedsReceivedInStablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ExternalDebtProceedsReceivedInStablecoin", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "External debt proceeds received in stablecoin" } } }, "auth_ref": [] }, "ptgef_FDanielSicilianoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FDanielSicilianoMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "F Daniel Siciliano [Member]" } } }, "auth_ref": [] }, "ptgef_FairValueOfContribution": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueOfContribution", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of contribution" } } }, "auth_ref": [] }, "ptgef_FairValueOfSharesIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueOfSharesIssuedForServices", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Fair value of shares issued for services" } } }, "auth_ref": [] }, "ptgef_FairValueOfWarrantPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueOfWarrantPerShare", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of warrant per share" } } }, "auth_ref": [] }, "ptgef_FairValueOfWarrantsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueOfWarrantsAmount", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants amount" } } }, "auth_ref": [] }, "ptgef_FairValueOfWarrantsAtIssuanceExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueOfWarrantsAtIssuanceExercisePrice", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants at issuance exercise price" } } }, "auth_ref": [] }, "ptgef_FairValueOfWarrantsShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueOfWarrantsShares", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants shares" } } }, "auth_ref": [] }, "ptgef_FairValueThroughProfitOrLossMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueThroughProfitOrLossMember", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Through Profit Or Loss [Member]" } } }, "auth_ref": [] }, "ptgef_FairValueToOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FairValueToOtherComprehensiveIncomeMember", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value To Other Comprehensive Income [Member]" } } }, "auth_ref": [] }, "ptgef_February152022Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "February152022Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "February 152022 [Member]" } } }, "auth_ref": [] }, "ifrs-full_FeeAndCommissionExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FeeAndCommissionExpense", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Fee and salary" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_FeeAndCommissionIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FeeAndCommissionIncome", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Bonus" } } }, "auth_ref": [ "r249" ] }, "ptgef_FixedAssetDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FixedAssetDepreciation", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Fixed asset depreciation" } } }, "auth_ref": [] }, "ptgef_FixedAssetDisposals": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "FixedAssetDisposals", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fixed asset disposals", "label": "FixedAssetDisposals" } } }, "auth_ref": [] }, "ptgef_ForeignCurrencyEffectAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ForeignCurrencyEffectAndOther", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Foreign currency effect and other" } } }, "auth_ref": [] }, "ptgef_ForfeitedAdvancedPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ForfeitedAdvancedPayments", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Forfeited advanced payments" } } }, "auth_ref": [] }, "ptgef_GPUDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GPUDepositsMember", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "G P U Deposits [Member]" } } }, "auth_ref": [] }, "ptgef_GPUsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GPUsMember", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "G P Us [Member]" } } }, "auth_ref": [] }, "ptgef_GainFromSaleOfInvestmentInPublicCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GainFromSaleOfInvestmentInPublicCompany", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 9.0 }, "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Gain from sale of investment in public company", "negatedLabel": "Gain from sale of investment in public company" } } }, "auth_ref": [] }, "ptgef_GainOnDissolutionOfInvestmentInAssociate": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GainOnDissolutionOfInvestmentInAssociate", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 8.0 }, "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Gain on dissolution of investment in associate", "negatedLabel": "Gain on dissolution of investment in associate" } } }, "auth_ref": [] }, "ptgef_GainOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GainOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 26.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Gain on extinguishment of debt", "verboseLabel": "Gain on forgiveness of loan interest" } } }, "auth_ref": [] }, "ptgef_GainOnSettlementOfTonPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GainOnSettlementOfTonPayable", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 21.0 }, "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails2", "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Gain on settlement of TON payable", "negatedLabel": "Gain on settlement of TON payable" } } }, "auth_ref": [] }, "ptgef_GainOnSettlementWithParexelIoxCro": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GainOnSettlementWithParexelIoxCro", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 9.0 }, "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 26.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on settlement with Parexel - iOx CRO", "label": "Gain on settlement with Parexel - iOx CRO" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnChangeInFairValueOfDerivatives", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Change in fair value of put right liability, net of redemptions" } }, "en": { "role": { "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r249" ] }, "ptgef_GainsLossesOnChangeInFairValueOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GainsLossesOnChangeInFairValueOfWarrants", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Change in fair value of warrant liability" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Foreign exchange transaction (loss) gain" } }, "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r13", "r121", "r154" ] }, "ifrs-full_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses" } } }, "auth_ref": [ "r244" ] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r104", "r181", "r190", "r192", "r195" ] }, "ifrs-full_GeographicalAreasDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GeographicalAreasDomain", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r104", "r181", "r190", "r192", "r195" ] }, "ptgef_GrantDate": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GrantDate", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Date" } } }, "auth_ref": [] }, "ptgef_GregoryHBaileyMDMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GregoryHBaileyMDMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Gregory H Bailey M D [Member]" } } }, "auth_ref": [] }, "ptgef_GrossProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "GrossProceeds", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds" } } }, "auth_ref": [] }, "ptgef_IOXMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IOXMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IOX [Member]" } } }, "auth_ref": [] }, "ptgef_IOxIPRDMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IOxIPRDMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "iOx IPR&D [Member]" } } }, "auth_ref": [] }, "ptgef_IanBWaltersMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IanBWaltersMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Ian B Walters [Member]" } } }, "auth_ref": [] }, "ptgef_IanBWaltersThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IanBWaltersThreeMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Ian B Walters Three [Member]" } } }, "auth_ref": [] }, "ptgef_IanBWaltersTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IanBWaltersTwoMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Ian B Walters Two [Member]" } } }, "auth_ref": [] }, "ptgef_IanWaltersMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IanWaltersMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Ian Walters [Member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r216", "r218", "r219" ] }, "ptgef_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IfrsStatementLineItems", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative", "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://portagebiotech.com/role/DigitalAssetsDetails1", "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1", "http://portagebiotech.com/role/LossPerShareDetails1", "http://portagebiotech.com/role/Non-controllingInterestDetails", "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails", "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3", "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails", "http://portagebiotech.com/role/StablecoinDetails", "http://portagebiotech.com/role/StablecoinDetails1", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit", "http://portagebiotech.com/role/StockOptionReserveDetails1", "http://portagebiotech.com/role/StockOptionReserveDetails2", "http://portagebiotech.com/role/StockOptionReserveDetails4", "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative", "http://portagebiotech.com/role/WarrantLiabilityDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4", "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "ptgef_ImmunoOncologyMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ImmunoOncologyMember", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Immuno Oncology [Member]" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentLoss", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetailsNarrative", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment loss", "verboseLabel": "Loss on impairment" } }, "en": { "role": { "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r28", "r29" ] }, "ptgef_ImpairmentLossInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ImpairmentLossInvestmentInCompedica", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment loss - investment in Compedica", "label": "Impairment loss - investment in Compedica" } } }, "auth_ref": [] }, "ptgef_ImpairmentLossIoxIprd": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ImpairmentLossIoxIprd", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Impairment loss - iOx IPR&D" } } }, "auth_ref": [] }, "ptgef_ImpairmentLossSaugatuck": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ImpairmentLossSaugatuck", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Impairment loss - Saugatuck" } } }, "auth_ref": [] }, "ptgef_ImpairmentLossStimunity": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ImpairmentLossStimunity", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Impairment loss - Stimunity" } } }, "auth_ref": [] }, "ptgef_ImpairmentLossTarusIprd": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ImpairmentLossTarusIprd", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Impairment loss - Tarus IPR&D" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentOfFinancialAssetsAxis", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "label": "Impairment of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r148" ] }, "ifrs-full_ImpairmentOfFinancialAssetsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentOfFinancialAssetsDomain", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Impairment of financial assets' axis if no other member is used." } } }, "auth_ref": [ "r148" ] }, "ptgef_IncomeLossOnOrdinaryActivitiesBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IncomeLossOnOrdinaryActivitiesBeforeTax", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Loss before income tax" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ptgef_IncomeTaxBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IncomeTaxBenefit", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Income tax benefit", "label": "IncomeTaxBenefit" } } }, "auth_ref": [] }, "ptgef_IncomeTaxEffectsRelatedToEquityCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IncomeTaxEffectsRelatedToEquityCompensation", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Income tax effects related to equity compensation" } } }, "auth_ref": [] }, "ptgef_IncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "IncomeTaxExpense", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Income tax in the statement of loss" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax benefit", "label": "Tax expense (income)" } } }, "auth_ref": [ "r1", "r2", "r3", "r18", "r62", "r95", "r112", "r113", "r114", "r178" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Decrease in cash, cash equivalents, restricted during period", "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r40", "r111" ] }, "ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInDeferredTaxLiabilityAsset", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease in deferred tax liability", "label": "Increase (decrease) in deferred tax liability (asset)" } }, "en": { "role": { "documentation": "The increase (decrease) in a deferred tax liability (asset). [Refer: Deferred tax liability (asset)]" } } }, "auth_ref": [ "r227" ] }, "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInNumberOfSharesOutstanding", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "pre-funded warrants outstanding shares" } }, "en": { "role": { "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]" } } }, "auth_ref": [ "r108", "r144", "r169" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Share-based compensation expense" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r152" ] }, "ptgef_InitialInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "InitialInvestmentInCompedica", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetails" ], "lang": { "en-us": { "role": { "label": "Initial investment in Compedica" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsMaterialToEntityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IntangibleAssetsMaterialToEntityAxis", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Intangible assets material to entity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r31", "r126" ] }, "ifrs-full_IntangibleAssetsMaterialToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IntangibleAssetsMaterialToEntityDomain", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets material to the entity. It also represents the standard value for the 'Intangible assets material to entity' axis if no other member is used. [Refer: Intangible assets material to entity]" } } }, "auth_ref": [ "r31", "r126" ] }, "ptgef_Interest": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Interest", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Less: Interest" } } }, "auth_ref": [] }, "ifrs-full_InterestExpenseIncomeDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestExpenseIncomeDefinedBenefitPlans", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Interest (expense) income, net" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_InterestRateBenchmarksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestRateBenchmarksAxis", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "Interest rate benchmarks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_InterestRateBenchmarksDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestRateBenchmarksDomain", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en": { "role": { "documentation": "This member stands for all interest rate benchmarks. It also represents the standard value for the 'Interest rate benchmarks' axis if no other member is used." } } }, "auth_ref": [ "r85" ] }, "ptgef_InvestmentInCompedicaAsOfMarch31": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "InvestmentInCompedicaAsOfMarch31", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetails" ], "lang": { "en-us": { "role": { "label": "Investment in Compedica as of March 31" } } }, "auth_ref": [] }, "ifrs-full_InvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentProperty", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investments" } }, "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } } }, "auth_ref": [ "r34", "r35", "r128", "r129", "r156" ] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Capital stock" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r198", "r203" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r153" ] }, "ptgef_JamesMellonMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "JamesMellonMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "James Mellon [Member]" } } }, "auth_ref": [] }, "ptgef_January132021Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "January132021Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "January 132021 [Member]" } } }, "auth_ref": [] }, "ptgef_January192022Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "January192022Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "January 192022 [Member]" } } }, "auth_ref": [] }, "ptgef_JeanChristopheRenondinMDMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "JeanChristopheRenondinMDMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Jean Christophe Renondin M D [Member]" } } }, "auth_ref": [] }, "ptgef_July272022Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "July272022Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "July 272022 [Member]" } } }, "auth_ref": [] }, "ptgef_July272026Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "July272026Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "July 272026 [Member]" } } }, "auth_ref": [] }, "ptgef_June82022Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "June82022Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "June 82022 [Member]" } } }, "auth_ref": [] }, "ptgef_JustinFairchildMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "JustinFairchildMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Justin Fairchild [Member]" } } }, "auth_ref": [] }, "ptgef_JustinStebbingMDPhDMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "JustinStebbingMDPhDMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Justin Stebbing M D Ph D [Member]" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Total" } } }, "auth_ref": [ "r14" ] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation expense" } } }, "auth_ref": [ "r15" ] }, "ptgef_LeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LeaseLiabilityCurrent", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liability - current", "label": "LeaseLiabilityCurrent" } } }, "auth_ref": [] }, "ptgef_LeaseLiabilityCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LeaseLiabilityCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Lease liability - current and noncurrent" } } }, "auth_ref": [] }, "ptgef_LeaseLiabilityFutureMinimumPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LeaseLiabilityFutureMinimumPaymentsDue", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "2027" } } }, "auth_ref": [] }, "ptgef_LeaseLiabilityFutureMinimumPaymentsYearDue": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LeaseLiabilityFutureMinimumPaymentsYearDue", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Total" } } }, "auth_ref": [] }, "ptgef_LeaseLiabilityFutureMinimumPaymentsYearTwoDue": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LeaseLiabilityFutureMinimumPaymentsYearTwoDue", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "2028" } } }, "auth_ref": [] }, "ptgef_LeaseLiabilityIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LeaseLiabilityIncurred", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Lease liability incurred" } } }, "auth_ref": [] }, "ptgef_LeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LeaseLiabilityNoncurrent", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liability - non-current", "label": "LeaseLiabilityNoncurrent" } } }, "auth_ref": [] }, "ptgef_Level1Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Level1Member", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "label": "Level 1 [Member]" } } }, "auth_ref": [] }, "ptgef_Level2Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Level2Member", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "label": "Level 2 [Member]" } } }, "auth_ref": [] }, "ptgef_Level3Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Level3Member", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "label": "Level 3 [Member]" } } }, "auth_ref": [] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r12", "r67", "r142" ] }, "ifrs-full_LevelsOfFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyDomain", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r12", "r67", "r142" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r66", "r67", "r68", "r96", "r100", "r141", "r142", "r163" ] }, "ptgef_LiabilitiesMeasuredFairValueRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LiabilitiesMeasuredFairValueRecurringBasisTableTextBlock", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Schedule of liabilities measured at fair value on a recurring basis" } } }, "auth_ref": [] }, "ptgef_LindaKozickMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LindaKozickMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Linda Kozick [Member]" } } }, "auth_ref": [] }, "ptgef_LoanTerminationFee": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LoanTerminationFee", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loan termination fee", "label": "LoanTerminationFee" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ptgef_LockedTonMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LockedTonMember", "presentation": [ "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Locked Ton [Member]" } } }, "auth_ref": [] }, "ptgef_LockedTonTokenDiscountForLackOfMarketabilityRate": { "xbrltype": "percentItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LockedTonTokenDiscountForLackOfMarketabilityRate", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails" ], "lang": { "en-us": { "role": { "label": "Locked TON token discount for lack of marketability rate" } } }, "auth_ref": [] }, "ptgef_LossFromEquityMethodInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossFromEquityMethodInvestment", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetails", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss from equity method investment", "negatedLabel": "Loss from equity method investment" } } }, "auth_ref": [] }, "ptgef_LossOnExercise": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnExercise", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "loss on the exercise" } } }, "auth_ref": [] }, "ptgef_LossOnExerciseOfPutRightLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnExerciseOfPutRightLiability", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss on exercise of put right liability" } } }, "auth_ref": [] }, "ptgef_LossOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnExtinguishmentOfDebt", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss on extinguishment of debt" } } }, "auth_ref": [] }, "ptgef_LossOnImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnImpairment", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetails" ], "lang": { "en-us": { "role": { "label": "Loss on impairment" } } }, "auth_ref": [] }, "ptgef_LossOnImpairmentInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnImpairmentInvestmentInCompedica", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss on impairment - investment in Compedica" } } }, "auth_ref": [] }, "ptgef_LossOnRegisteredDirectOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnRegisteredDirectOffering", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 }, "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on Registered Direct Offering", "label": "Loss on Registered Direct Offering" } } }, "auth_ref": [] }, "ptgef_LossOnRemeasurementOfInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnRemeasurementOfInvestmentInCompedica", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss on remeasurement of investment in Compedica" } } }, "auth_ref": [] }, "ptgef_LossOnRevaluationOfDigitalAssetReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnRevaluationOfDigitalAssetReceivables", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on revaluation of digital asset receivables", "label": "Loss on revaluation of digital asset receivables" } } }, "auth_ref": [] }, "ptgef_LossOnRevaluationOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnRevaluationOfDigitalAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on revaluation of digital assets", "label": "Loss on revaluation of digital assets" } } }, "auth_ref": [] }, "ptgef_LossOnRevaluationOfInvestmentInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnRevaluationOfInvestmentInCompedica", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on revaluation of investment in Compedica", "label": "Loss on revaluation of investment in Compedica" } } }, "auth_ref": [] }, "ptgef_LossOnSettlementOfPutRightLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossOnSettlementOfPutRightLiability", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 23.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on settlement of put right liability", "label": "Loss on settlement of put right liability" } } }, "auth_ref": [] }, "ptgef_LossPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossPerShareBasic", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Loss per share, Basic", "label": "LossPerShareBasic" } } }, "auth_ref": [] }, "ptgef_LossPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "LossPerShareDiluted", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Loss per share, Diluted", "label": "LossPerShareDiluted" } } }, "auth_ref": [] }, "ptgef_March112026Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "March112026Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "March 112026 [Member]" } } }, "auth_ref": [] }, "ptgef_March302023Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "March302023Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "March 302023 [Member]" } } }, "auth_ref": [] }, "ptgef_March72025Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "March72025Member", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "March 72025 [Member]" } } }, "auth_ref": [] }, "ptgef_MarkSimonMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "MarkSimonMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Mark Simon [Member]" } } }, "auth_ref": [] }, "ptgef_MarketValueNumberofShareUnitsofStockThetHaveNotVested": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "MarketValueNumberofShareUnitsofStockThetHaveNotVested", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Market Value Number of Share Units of Stock Thet Have Not Vested" } } }, "auth_ref": [] }, "ptgef_MasterLoanAgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "MasterLoanAgreementDescription", "presentation": [ "http://portagebiotech.com/role/BitgoPrimeLoanDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Master Loan Agreement description" } } }, "auth_ref": [] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails2", "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r33", "r37", "r66", "r130", "r141" ] }, "ifrs-full_MeasurementDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MeasurementDomain", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails2", "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r33", "r37", "r66", "r130", "r141" ] }, "ptgef_MichaelTerpinMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "MichaelTerpinMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Michael Terpin [Member]" } } }, "auth_ref": [] }, "ptgef_NatureOfOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NatureOfOperationsExplanatory", "presentation": [ "http://portagebiotech.com/role/NatureOfOperations" ], "lang": { "en-us": { "role": { "label": "NATURE OF OPERATIONS" } } }, "auth_ref": [] }, "ptgef_NetChangeInWorkingCapitalComponentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetChangeInWorkingCapitalComponentsAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating working capital:" } } }, "auth_ref": [] }, "ptgef_NetDeferredTaxAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetDeferredTaxAsset", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax asset", "label": "NetDeferredTaxAsset" } } }, "auth_ref": [] }, "ifrs-full_NetDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NetDeferredTaxAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/IncomeTaxesDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Net deferred tax assets" } }, "en": { "role": { "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r226" ] }, "ifrs-full_NetForeignExchangeGain": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NetForeignExchangeGain", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign exchange transaction (loss) gain", "label": "Net foreign exchange gain" } } }, "auth_ref": [ "r232", "r246" ] }, "ptgef_NetGain": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetGain", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net gain" } } }, "auth_ref": [] }, "ptgef_NetLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetLossAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/Non-controllingInterestDetails" ], "lang": { "en-us": { "role": { "label": "Net (loss) attributable to non-controlling interest" } } }, "auth_ref": [] }, "ptgef_NetLossIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetLossIncome", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net Loss Income" } } }, "auth_ref": [] }, "ptgef_NetProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetProceeds", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "net proceeds" } } }, "auth_ref": [] }, "ptgef_NetUnrealizedLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetUnrealizedLossOnInvestments", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Net unrealized loss on investments" } } }, "auth_ref": [] }, "ptgef_NetworkingEquipmentCost": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NetworkingEquipmentCost", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Networking equipment cost" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoTradingSymbolFlag", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ptgef_NoncashInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NoncashInterestExpense", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 25.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Noncash interest expense" } } }, "auth_ref": [] }, "ptgef_NoncashInvestingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NoncashInvestingItemsAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash investing and financing activities:" } } }, "auth_ref": [] }, "ptgef_NoncashOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NoncashOperatingActivitiesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash operating activities:" } } }, "auth_ref": [] }, "ptgef_NoncontrollingInterestIncreasedUponConversion": { "xbrltype": "percentItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NoncontrollingInterestIncreasedUponConversion", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-controlling interest increased upon conversion" } } }, "auth_ref": [] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/Non-controllingInterestDetails", "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-controlling interest", "periodStartLabel": "Non-controlling interest, at beginning", "periodEndLabel": "Non-controlling interest, at ending" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r46", "r50", "r161" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests [member]" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r153" ] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Non-current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r54", "r165", "r186" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Lease liability - non-current" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r73" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Non-current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r56", "r166", "r186" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentWarrantLiability", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Warrant liability" } }, "en": { "role": { "documentation": "The amount of non-current warrant liabilities. [Refer: Warrant liability]" } } }, "auth_ref": [ "r247" ] }, "ptgef_NondeductibleExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NondeductibleExpenses", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Nondeductible expenses" } } }, "auth_ref": [] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "ptgef_NumberOfOutstandingShareOption": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberOfOutstandingShareOption", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "NumberOfOutstandingShareOption" } } }, "auth_ref": [] }, "ifrs-full_NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfPotentialOrdinarySharesThatAreAntidilutiveInPeriodPresented", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Anti-dilutive effect on loss per share" } }, "en": { "role": { "documentation": "Number of potential ordinary shares that are antidilutive in the period presented." } } }, "auth_ref": [ "r233" ] }, "ptgef_NumberOfShareOptionsAvailableForFutureAwardsSharebasedPaymentsArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberOfShareOptionsAvailableForFutureAwardsSharebasedPaymentsArrangement", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "label": "Available for future awards" } } }, "auth_ref": [] }, "ptgef_NumberOfShareOptionsExercisableInSharebasedPaymentsArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentsArrangements", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "label": "Exercisable as at end" } } }, "auth_ref": [] }, "ptgef_NumberOfShareOptionsExpiredOrForfeitedInSharebasedPaymentsArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberOfShareOptionsExpiredOrForfeitedInSharebasedPaymentsArrangement", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "label": "Expired or forfeited" } } }, "auth_ref": [] }, "ptgef_NumberOfShareOptionsGrantedInSharebasedPaymentsArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentsArrangement", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "label": "Granted" } } }, "auth_ref": [] }, "ptgef_NumberOfSharesExercise": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberOfSharesExercise", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued" } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Pre-funded warrants issued", "verboseLabel": "Shares issued", "terseLabel": "Shares ot units" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r243" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Begnning balance, shares", "periodEndLabel": "Ending Balance, shares", "label": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r108", "r144", "r169" ] }, "ptgef_NumberOfSharesSold": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberOfSharesSold", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares sold" } } }, "auth_ref": [] }, "ptgef_NumberofSecuritiesUnderlyingUnexercisedOptionsUnExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberofSecuritiesUnderlyingUnexercisedOptionsUnExercisable", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Number of Securities Underlying Unexercised Options Un Exercisable" } } }, "auth_ref": [] }, "ptgef_NumberofShareUnitsofStockThetHaveNotVested": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "NumberofShareUnitsofStockThetHaveNotVested", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Number of Share Units of Stock Thet Have Not Vested" } } }, "auth_ref": [] }, "ptgef_OfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OfferingCosts", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 }, "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Offering costs", "label": "Offering costs" } } }, "auth_ref": [] }, "ptgef_OptionExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OptionExpirationDate", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Option Expiration Date" } } }, "auth_ref": [] }, "ptgef_OptionLifeShareOptions": { "xbrltype": "durationItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OptionLifeShareOptions", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4" ], "lang": { "en-us": { "role": { "label": "Expected life" } } }, "auth_ref": [] }, "ptgef_OptionLifeShareOptionsGranted": { "xbrltype": "durationItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OptionLifeShareOptionsGranted", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected life", "label": "OptionLifeShareOptionsGranted" } } }, "auth_ref": [] }, "ptgef_OrdinarySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OrdinarySharesIssued", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares issued" } } }, "auth_ref": [] }, "ptgef_OtherAccruedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OtherAccruedExpenses", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other" } } }, "auth_ref": [] }, "ifrs-full_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r247" ] }, "ptgef_OtherAssetsLongTermPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OtherAssetsLongTermPortion", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesOtherReceivablesAndOtherAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other assets long term portion" } } }, "auth_ref": [] }, "ptgef_OtherCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OtherCompensation", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Other compensation" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive loss" } } }, "auth_ref": [] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r197", "r202" ] }, "ifrs-full_OtherLongtermBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherLongtermBenefits", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Other long-term benefits" } } }, "auth_ref": [ "r229" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r218" ] }, "ifrs-full_OtherReserves": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherReserves", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Stock option reserve" } }, "en": { "role": { "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]" } } }, "auth_ref": [ "r198", "r203" ] }, "ptgef_OutstandingContingentPutOptionsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "OutstandingContingentPutOptionsFairValue", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Outstanding Contingent Put Options fair value" } } }, "auth_ref": [] }, "ptgef_PBI2021EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PBI2021EquityIncentivePlanMember", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails1" ], "lang": { "en-us": { "role": { "label": "PBI 2021 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "ptgef_PayablesAndAccruedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PayablesAndAccruedExpense", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/CapitalManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payables and accrued expenses" } } }, "auth_ref": [] }, "ifrs-full_PaymentsForShareIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsForShareIssueCosts", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Share issuance costs", "label": "Payments for share issue costs" } }, "en": { "role": { "documentation": "The cash outflow for share issue costs." } } }, "auth_ref": [ "r236" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of lease liability", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r184" ] }, "ptgef_PaymentsOnExternalDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PaymentsOnExternalDebt", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on external debt", "label": "PaymentsOnExternalDebt" } } }, "auth_ref": [] }, "ptgef_PaymentsOnExternalDebtUsingDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PaymentsOnExternalDebtUsingDigitalAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments on external debt using digital assets" } } }, "auth_ref": [] }, "ptgef_PlacementAgentWarrants2026Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PlacementAgentWarrants2026Member", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Placement Agent Warrants 2026 [Member]" } } }, "auth_ref": [] }, "ptgef_PlacementAgentWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PlacementAgentWarrantsMember", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4", "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Placement Agent Warrants [Member]" } } }, "auth_ref": [] }, "ptgef_PlacementAgentsWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PlacementAgentsWarrantsMember", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails4" ], "lang": { "en-us": { "role": { "label": "Placement Agents Warrants [Member]" } } }, "auth_ref": [] }, "ifrs-full_PostemploymentBenefitExpenseInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PostemploymentBenefitExpenseInProfitOrLoss", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Post-employment benefits" } } }, "auth_ref": [ "r231" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r212" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r214" ] }, "ptgef_PrefundedWarrantsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrefundedWarrantsExercised", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Pre-Funded warrants exercised" } } }, "auth_ref": [] }, "ptgef_PrefundedWarrantsExercisedShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrefundedWarrantsExercisedShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Pre-Funded warrants exercised, shares" } } }, "auth_ref": [] }, "ptgef_PrepaidExpensesAndOtherReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrepaidExpensesAndOtherReceivable", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets" } } }, "auth_ref": [] }, "ptgef_PrepaidExpensesAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrepaidExpensesAndOtherReceivables", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "prepaid expenses and other receivables" } } }, "auth_ref": [] }, "ptgef_PrepaidExpensesObtainedInExchangeForStablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrepaidExpensesObtainedInExchangeForStablecoin", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses obtained in exchange for stablecoin" } } }, "auth_ref": [] }, "ptgef_PrepaidGpuInfrastructureCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrepaidGpuInfrastructureCosts", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid GPU infrastructure costs" } } }, "auth_ref": [] }, "ptgef_PrepaidGpuLeasesShortterm": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrepaidGpuLeasesShortterm", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid GPU leases, short-term" } } }, "auth_ref": [] }, "ptgef_PrepaidInvestorRelations": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PrepaidInvestorRelations", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid investor relations" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromExerciseOfOptions", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Exercise of side letter put right" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of options." } } }, "auth_ref": [ "r236" ] }, "ptgef_ProceedsFromExerciseOfPrefundedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProceedsFromExerciseOfPrefundedWarrants", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercise of Pre-Funded Warrants" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromExerciseOfWarrants", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } } }, "auth_ref": [ "r236" ] }, "ptgef_ProceedsFromExternalDebtDrawdown": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProceedsFromExternalDebtDrawdown", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Proceeds from external debt drawdown" } } }, "auth_ref": [] }, "ptgef_ProceedsFromRegisteredDirectOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProceedsFromRegisteredDirectOffering", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Registered Direct Offering" } } }, "auth_ref": [] }, "ptgef_ProceedsFromSaleOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProceedsFromSaleOfDigitalAssets", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of digital assets" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromSalesOfInvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOfInvestmentProperty", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of investment in public company" } }, "en": { "role": { "documentation": "The cash inflow from sales of investment property. [Refer: Investment property]" } } }, "auth_ref": [ "r235" ] }, "ptgef_ProceedsFromSharesIssuedUnderAtmAndCommittedPurchaseAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProceedsFromSharesIssuedUnderAtmAndCommittedPurchaseAgreement", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from shares issued under ATM and Committed Purchase Agreement" } } }, "auth_ref": [] }, "ptgef_ProceedsFromSharesIssuedUnderPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProceedsFromSharesIssuedUnderPrivatePlacement", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from shares issued under private placement" } } }, "auth_ref": [] }, "ptgef_Proceedsfromexerciseofwarrant": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Proceedsfromexerciseofwarrant", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ProceedsFromExerciseOfWarrants" } } }, "auth_ref": [] }, "ptgef_ProfessionalFeesExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProfessionalFeesExpenses", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/AccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued legal fees" } } }, "auth_ref": [] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss for the period" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r43", "r45", "r96", "r98", "r124", "r132", "r151", "r171", "r186", "r191" ] }, "ifrs-full_ProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAbstract", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Expenses", "verboseLabel": "Segment expenses" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Net loss attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-controlling interest", "label": "Profit (loss), attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r49", "r173" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Owners of the Company" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r174" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before benefit for income taxes", "label": "Profit (loss) before tax" } } }, "auth_ref": [ "r83", "r193", "r194", "r199", "r200" ] }, "ptgef_ProfitLossFromContinuingOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ProfitLossFromContinuingOperation", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income tax benefit" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperations", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Net loss for the year" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]" } } }, "auth_ref": [ "r59", "r96", "r98", "r171" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Segment loss from operations" } } }, "auth_ref": [ "r182", "r249" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails", "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Property, plant, and equipment, net", "verboseLabel": "Property plant equipment carrying amount" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r7", "r117", "r155" ] }, "ptgef_PropertyPlantAndEquipmentAndRightOfUseAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PropertyPlantAndEquipmentAndRightOfUseAssetsTextBlock", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssets" ], "lang": { "en-us": { "role": { "label": "PROPERTY, PLANT, AND EQUIPMENT AND RIGHT-OF-USE ASSETS" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "As of March 31, 2025", "periodEndLabel": "As of March 31, 2026", "label": "Property, plant and equipment, revalued assets, at cost" } }, "en": { "role": { "documentation": "The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r10", "r119" ] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of ownership subsidiary" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r19", "r21", "r51" ] }, "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-controlling interest", "label": "Proportion of ownership interests held by non-controlling interests" } }, "en": { "role": { "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]" } } }, "auth_ref": [ "r48" ] }, "ifrs-full_ProportionOfVotingPowerHeldInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProportionOfVotingPowerHeldInSubsidiary", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of outstanding shares" } }, "en": { "role": { "documentation": "The proportion of the voting rights in a subsidiary held by the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r19", "r21", "r51" ] }, "ptgef_PurchaseEquipmentPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PurchaseEquipmentPayment", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase equipment payment" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of fixed assets", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r183" ] }, "ptgef_PurchasePrice": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PurchasePrice", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Purchase price", "label": "PurchasePrice" } } }, "auth_ref": [] }, "ptgef_PurchasePriceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PurchasePriceLeaseLiability", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price" } } }, "auth_ref": [] }, "ptgef_PurchasesOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PurchasesOfDigitalAssets", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of digital assets", "label": "PurchasesOfDigitalAssets" } } }, "auth_ref": [] }, "ptgef_PurchasesOfStablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PurchasesOfStablecoin", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of stablecoin", "label": "Purchases of stablecoin" } } }, "auth_ref": [] }, "ptgef_PutRightIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightIssuanceCosts", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Put right issuance costs", "label": "PutRightIssuanceCosts" } } }, "auth_ref": [] }, "ptgef_PutRightLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightLiabilities", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/CapitalManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Put right liabilities" } } }, "auth_ref": [] }, "ptgef_PutRightLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightLiability", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1", "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Put right liability" } } }, "auth_ref": [] }, "ptgef_PutRightLiabilityEndingBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightLiabilityEndingBalance", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Put right liability as of March 31" } } }, "auth_ref": [] }, "ptgef_PutRightLiabilityemainingTermInYears": { "xbrltype": "durationItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightLiabilityemainingTermInYears", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails" ], "lang": { "en-us": { "role": { "label": "Remaining term (in years)" } } }, "auth_ref": [] }, "ptgef_PutRightsExercisedAndReturnOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightsExercisedAndReturnOfShares", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Put rights exercised and return of shares" } } }, "auth_ref": [] }, "ptgef_PutRightsExercisedAndReturnShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightsExercisedAndReturnShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Put rights exercised and return, shares" } } }, "auth_ref": [] }, "ptgef_PutRightsIssuedToInvestors": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "PutRightsIssuedToInvestors", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Put rights issued to investors" } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r39", "r71", "r76", "r81", "r110", "r187", "r188", "r241" ] }, "ifrs-full_RangeDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RangeDomain", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r39", "r71", "r76", "r81", "r110", "r187", "r188", "r241" ] }, "ptgef_RealizedLossGainOnSaleOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RealizedLossGainOnSaleOfDigitalAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Realized (loss) gain on sale of digital assets" } } }, "auth_ref": [] }, "ptgef_RealizedLossOnNovationOfDigitalAssetReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RealizedLossOnNovationOfDigitalAssetReceivables", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Realized loss on novation of digital asset receivables" } } }, "auth_ref": [] }, "ptgef_RealizedLossOnNovationOfDigitalAssetsToInvestor": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RealizedLossOnNovationOfDigitalAssetsToInvestor", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Realized loss on novation of digital assets to investor", "label": "Realized loss on novation of digital assets to investor" } } }, "auth_ref": [] }, "ptgef_RealizedLossOnSaleOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RealizedLossOnSaleOfDigitalAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 7.0 }, "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Realized loss on sale of digital assets", "label": "Realized loss on sale of digital assets" } } }, "auth_ref": [] }, "ptgef_ReceiptOfDigitalAssetReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ReceiptOfDigitalAssetReceivables", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Receipt of digital asset receivables" } } }, "auth_ref": [] }, "ptgef_ReceiptOfDigitalAssetsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ReceiptOfDigitalAssetsReceivable", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Receipt of digital assets receivable" } } }, "auth_ref": [] }, "ptgef_ReceiptOfDigitalAssetsReceivableTonTokens": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ReceiptOfDigitalAssetsReceivableTonTokens", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Receipt of digital assets receivable, TON tokens" } } }, "auth_ref": [] }, "ptgef_RemeasurementChangeInFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RemeasurementChangeInFairValue", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Remeasurement change in fair value" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Research and development" } } }, "auth_ref": [ "r32", "r127" ] }, "ptgef_ReservesAndAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ReservesAndAccruals", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/IncomeTaxesDetails2": { "parentTag": "ifrs-full_NetDeferredTaxAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Reserves and accruals" } } }, "auth_ref": [] }, "ifrs-full_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Restricted cash" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r247" ] }, "ptgef_RestrictedCashOnHand": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RestrictedCashOnHand", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted cash on hand" } } }, "auth_ref": [] }, "ifrs-full_RestrictedShareUnitsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RestrictedShareUnitsMember", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted share units [member]" } }, "en": { "role": { "documentation": "This member stands for restricted share units." } } }, "auth_ref": [ "r233" ] }, "ptgef_RestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RestrictedStockUnitsMember", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails1", "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units [Member]" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r198", "r203", "r204" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r153", "r201" ] }, "ptgef_ReturnOfInvestmentInterestToCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ReturnOfInvestmentInterestToCompedica", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaDetails" ], "lang": { "en-us": { "role": { "label": "Return of investment interest to Compedica" } } }, "auth_ref": [] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Revenues", "verboseLabel": "Segment revenues" } } }, "auth_ref": [ "r58", "r83", "r93", "r97", "r102", "r103", "r105", "r177", "r186", "r199", "r200" ] }, "ptgef_RevenueReceivedInDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RevenueReceivedInDigitalAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Revenue received in digital assets" } } }, "auth_ref": [] }, "ptgef_ReversalOfSharebasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ReversalOfSharebasedCompensation", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reversal of share-based compensation" } } }, "auth_ref": [] }, "ptgef_RightOfUseAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RightOfUseAssetMember", "presentation": [ "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Right Of Use Asset [Member]" } } }, "auth_ref": [] }, "ptgef_RightToUseAssetAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RightToUseAssetAcquired", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Right-of-use asset acquired" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Right-of-use asset" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r72", "r75", "r107" ] }, "ptgef_RobertGlassmanMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RobertGlassmanMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Robert Glassman [Member]" } } }, "auth_ref": [] }, "ptgef_RobertKramerMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RobertKramerMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Robert Kramer [Member]" } } }, "auth_ref": [] }, "ptgef_RobertKramerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RobertKramerThreeMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Robert Kramer Three [Member]" } } }, "auth_ref": [] }, "ptgef_RobertKramerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "RobertKramerTwoMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Robert Kramer Two [Member]" } } }, "auth_ref": [] }, "ptgef_SaleOfDigitalAssetsSettledInStablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SaleOfDigitalAssetsSettledInStablecoin", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Sale of digital assets settled in stablecoin" } } }, "auth_ref": [] }, "ptgef_SaleOfStock": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SaleOfStock", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative", "http://portagebiotech.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock", "verboseLabel": "sale of stock" } } }, "auth_ref": [] }, "ptgef_SalesOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SalesOfDigitalAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Sales of digital assets" } } }, "auth_ref": [] }, "ptgef_SalesOfStablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SalesOfStablecoin", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Sales of stablecoin" } } }, "auth_ref": [] }, "ptgef_SalvaRxMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SalvaRxMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Salva Rx [Member]" } } }, "auth_ref": [] }, "ptgef_SaugatuckMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SaugatuckMember", "presentation": [ "http://portagebiotech.com/role/Non-controllingInterestDetails", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Saugatuck [Member]" } } }, "auth_ref": [] }, "ptgef_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of inputs associated with calculating the fair value", "label": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" } } }, "auth_ref": [] }, "ptgef_ScheduleOfAntiDilutiveEffectTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfAntiDilutiveEffectTableTextBlock", "presentation": [ "http://portagebiotech.com/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of anti-dilutive effect on loss per share", "label": "ScheduleOfAntiDilutiveEffectTableTextBlock" } } }, "auth_ref": [] }, "ptgef_ScheduleOfCompensationPayableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfCompensationPayableTableTextBlock", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of compensation payable" } } }, "auth_ref": [] }, "ptgef_ScheduleOfDeferredTaxAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfDeferredTaxAssetsTableTextBlock", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred tax assets and liabilities" } } }, "auth_ref": [] }, "ptgef_ScheduleOfDigitalAssetsPurchasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfDigitalAssetsPurchasesTableTextBlock", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of digital assets purchases" } } }, "auth_ref": [] }, "ptgef_ScheduleOfDigitalAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfDigitalAssetsTableTextBlock", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Digital assets" } } }, "auth_ref": [] }, "ptgef_ScheduleOfEarningsPerShareTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfEarningsPerShareTableTextBlock", "presentation": [ "http://portagebiotech.com/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of loss and share data used in the basic and diluted EPS calculations" } } }, "auth_ref": [] }, "ptgef_ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfFairValueOfThePutRightLiabilityIsEstimatedUsingBlackScholesModelTableTextBlock", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of put right liability" } } }, "auth_ref": [] }, "ptgef_ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "[custom:ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock]" } } }, "auth_ref": [] }, "ptgef_ScheduleOfIncomeTaxesBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfIncomeTaxesBenefitTableTextBlock", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of income tax benefit" } } }, "auth_ref": [] }, "ptgef_ScheduleOfInvestmentBalanceTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfInvestmentBalanceTableTextBlock", "presentation": [ "http://portagebiotech.com/role/InvestmentInCompedicaTables" ], "lang": { "en-us": { "role": { "label": "Schedule of investment balance" } } }, "auth_ref": [] }, "ptgef_ScheduleOfLeaseLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfLeaseLiabilityTableTextBlock", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Lease liability" } } }, "auth_ref": [] }, "ptgef_ScheduleOfNoncontrollingInterestTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfNoncontrollingInterestTableTextBlock", "presentation": [ "http://portagebiotech.com/role/Non-controllingInterestTables" ], "lang": { "en-us": { "role": { "label": "Schedule of non-controlling interest" } } }, "auth_ref": [] }, "ptgef_ScheduleOfOutstandingEquityAwardsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfOutstandingEquityAwardsTableTextBlock", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of outstanding equity awards" } } }, "auth_ref": [] }, "ptgef_ScheduleOfPutRightLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfPutRightLiabilityTableTextBlock", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of put right liability", "label": "ScheduleOfPutRightLiabilityTableTextBlock" } } }, "auth_ref": [] }, "ptgef_ScheduleOfReceivablesDigitalAssetsTableXextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfReceivablesDigitalAssetsTableXextBlock", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of movements in Receivables \u2013 digital assets" } } }, "auth_ref": [] }, "ptgef_ScheduleOfReconciliationEffectiveIncomeTaxratesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfReconciliationEffectiveIncomeTaxratesTableTextBlock", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation income tax rates" } } }, "auth_ref": [] }, "ptgef_ScheduleOfSegmentReportingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfSegmentReportingTableTextBlock", "presentation": [ "http://portagebiotech.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of segment reporting" } } }, "auth_ref": [] }, "ptgef_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveTables" ], "lang": { "en-us": { "role": { "label": "Schedule of share options issued and outstanding" } } }, "auth_ref": [] }, "ptgef_ScheduleOfShareBasedCompensationStocksOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfShareBasedCompensationStocksOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share options granted and outstanding" } } }, "auth_ref": [] }, "ptgef_ScheduleOfTermsStockOptionReserveTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfTermsStockOptionReserveTableTextBlock", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stock option reserve" } } }, "auth_ref": [] }, "ptgef_ScheduleOfTonPayableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfTonPayableTableTextBlock", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of TON payable" } } }, "auth_ref": [] }, "ptgef_ScheduleOfWarrantLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfWarrantLiabilityTableTextBlock", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of changes in the warrant liability" } } }, "auth_ref": [] }, "ptgef_ScheduleOfWeightedAverageAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ScheduleOfWeightedAverageAssumptionsTableTextBlock", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveTables" ], "lang": { "en-us": { "role": { "label": "Schedule of weighted-average estimated fair value of share options" } } }, "auth_ref": [] }, "ptgef_SecuritiesUnderOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SecuritiesUnderOptionsGranted", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Securities under option granted" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r206" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12gTitle", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r210" ] }, "ptgef_SecurityDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SecurityDeposits", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://portagebiotech.com/role/PrepaidExpensesOtherReceivablesAndOtherAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Security deposits", "verboseLabel": "Security deposit" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r209" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityReportingObligation", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r215" ] }, "ptgef_SegmentLossBeforeBenefitForIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SegmentLossBeforeBenefitForIncomeTaxes", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Segment loss before benefit for income taxes" } } }, "auth_ref": [] }, "ptgef_SegmentNetLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SegmentNetLoss", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails" ], "lang": { "en-us": { "role": { "label": "Segment net loss" } } }, "auth_ref": [] }, "ptgef_SeheduleOfTonTokensTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SeheduleOfTonTokensTableTextBlock", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsTables" ], "lang": { "en-us": { "role": { "label": "[custom:SeheduleOfTonTokensTableTextBlock]" } } }, "auth_ref": [] }, "ptgef_SeiesBWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SeiesBWarrantsMember", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Seies B Warrants [Member]" } } }, "auth_ref": [] }, "ptgef_SeiesCWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SeiesCWarrantsMember", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Seies C Warrants [Member]" } } }, "auth_ref": [] }, "ptgef_SeriesAWarrantsAndPreFundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SeriesAWarrantsAndPreFundedWarrantsMember", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series A Warrants And Pre Funded Warrants [Member]" } } }, "auth_ref": [] }, "ptgef_SeriesBWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SeriesBWarrantsMember", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Series B Warrants [Member]" } } }, "auth_ref": [] }, "ptgef_SeriesCWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SeriesCWarrantsMember", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails2" ], "lang": { "en-us": { "role": { "label": "Series C Warrants [Member]" } } }, "auth_ref": [] }, "ptgef_ServiceFees": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ServiceFees", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "service fees" } } }, "auth_ref": [] }, "ptgef_SettlementOfDwfMaasLimitedPutRight": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SettlementOfDwfMaasLimitedPutRight", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails1" ], "lang": { "en-us": { "role": { "label": "Settlement of DWF Maas Limited put right" } } }, "auth_ref": [] }, "ptgef_SettlementOfPutRightLiabilityUsingDigitalAssetReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SettlementOfPutRightLiabilityUsingDigitalAssetReceivables", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Settlement of put right liability using digital asset receivables" } } }, "auth_ref": [] }, "ptgef_SettlementOfPutRightLiabilityUsingDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SettlementOfPutRightLiabilityUsingDigitalAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Settlement of put right liability using digital assets", "label": "SettlementOfPutRightLiabilityUsingDigitalAssets" } } }, "auth_ref": [] }, "ptgef_SettlementOfPutRightLiabilityUsingStablecoinReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SettlementOfPutRightLiabilityUsingStablecoinReceivable", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Settlement of put right liability using stablecoin receivable" } } }, "auth_ref": [] }, "ptgef_ShareBasedCompensationExpenseUnvestedShareOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ShareBasedCompensationExpenseUnvestedShareOptions", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation expense unvested share options" } } }, "auth_ref": [] }, "ptgef_ShareIssuanceCostsSettledInCompanyStock": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ShareIssuanceCostsSettledInCompanyStock", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share issuance costs settled in Company stock" } } }, "auth_ref": [] }, "ptgef_ShareIssuanceCostsSettledInWarrantsOnCompanysStock": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ShareIssuanceCostsSettledInWarrantsOnCompanysStock", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share issuance costs settled in warrants on the Company's stock" } } }, "auth_ref": [] }, "ptgef_ShareOfLossInAssociate": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ShareOfLossInAssociate", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 29.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share of loss in associate" } } }, "auth_ref": [] }, "ptgef_ShareOfLossesFromEquityMethodInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ShareOfLossesFromEquityMethodInvestment", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 27.0 } }, "presentation": [ "http://portagebiotech.com/role/SegmentReportingDetails", "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Share of losses from equity method investment", "label": "Share of losses from equity method investment" } } }, "auth_ref": [] }, "ptgef_ShareOptions": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ShareOptions", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails4" ], "lang": { "en-us": { "role": { "label": "Share Options" } } }, "auth_ref": [] }, "ptgef_SharePriceFairvalue": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharePriceFairvalue", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4" ], "lang": { "en-us": { "role": { "label": "Share price" } } }, "auth_ref": [] }, "ptgef_SharebasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharebasedCompensationExpense", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Share based compensation expense", "label": "SharebasedCompensationExpense" } } }, "auth_ref": [] }, "ptgef_SharebasedPaymentCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharebasedPaymentCompensation", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-based payment compensation" } } }, "auth_ref": [] }, "ptgef_SharesFromRSUDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesFromRSUDistribution", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Shares from RSU distribution" } } }, "auth_ref": [] }, "ptgef_SharesIssuedAccruedForBonusesShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedAccruedForBonusesShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued accrued for bonuses, shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedForAccruedBonuses": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedForAccruedBonuses", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued for accrued bonuses" } } }, "auth_ref": [] }, "ptgef_SharesIssuedGrantedRsu": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedGrantedRsu", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued granted RSU" } } }, "auth_ref": [] }, "ptgef_SharesIssuedOrAccruedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedOrAccruedForServices", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued or accrued for services" } } }, "auth_ref": [] }, "ptgef_SharesIssuedOrAccruedForServicesShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedOrAccruedForServicesShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued or accrued for services, shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedPursuantToDistributionOfRestrictedStockUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedPursuantToDistributionOfRestrictedStockUnits", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued pursuant to distribution of restricted stock units" } } }, "auth_ref": [] }, "ptgef_SharesIssuedPursuantToDistributionOfRestrictedStockUnitsShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedPursuantToDistributionOfRestrictedStockUnitsShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued pursuant to distribution of restricted stock units, shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedRelatedToAtmAgreementNetOfShareIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedRelatedToAtmAgreementNetOfShareIssuanceCosts", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued related to the ATM agreement, net of share issuance costs" } } }, "auth_ref": [] }, "ptgef_SharesIssuedRelatedToAtmAgreementNetOfShareIssuanceCostsShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedRelatedToAtmAgreementNetOfShareIssuanceCostsShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued related to the ATM agreement, net of share issuance costs , shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedRelatingToAcquisitionOfCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedRelatingToAcquisitionOfCompedica", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued relating to the acquisition of Compedica" } } }, "auth_ref": [] }, "ptgef_SharesIssuedRelatingToAcquisitionOfCompedicaShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedRelatingToAcquisitionOfCompedicaShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued relating to the acquisition of Compedica, shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCosts", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under private placement, net of share issuance costs" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCostsAndPutRights": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCostsAndPutRights", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under private placement, net of share issuance costs and put rights" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCostsAndPutRightsShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCostsAndPutRightsShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under private placement, net of share issuance costs and put rights , shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCostsShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderPrivatePlacementNetOfShareIssuanceCostsShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under private placement, net of share issuance costs, shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderRegisteredDirectOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderRegisteredDirectOffering", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under Registered Direct Offering" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderRegisteredDirectOfferingNetOfShareIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderRegisteredDirectOfferingNetOfShareIssuanceCosts", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under registered direct offering, net of share issuance costs" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderRegisteredDirectOfferingNetOfShareIssuanceCostsShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderRegisteredDirectOfferingNetOfShareIssuanceCostsShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under registered direct offering, net of share issuance costs , shares" } } }, "auth_ref": [] }, "ptgef_SharesIssuedUnderRegisteredDirectOfferingShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesIssuedUnderRegisteredDirectOfferingShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares issued under Registered Direct Offering, shares" } } }, "auth_ref": [] }, "ptgef_SharesPrice": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesPrice", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Share price", "label": "SharesPrice" } } }, "auth_ref": [] }, "ptgef_SharesRepurchasedIntoTreasuryEmployeePayrollTaxes": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SharesRepurchasedIntoTreasuryEmployeePayrollTaxes", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares repurchased into treasury employee payroll taxes" } } }, "auth_ref": [] }, "ifrs-full_ShorttermEmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermEmployeeBenefitsExpense", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Short-term employee benefits (salary, bonus, etc.)" } } }, "auth_ref": [ "r244" ] }, "ifrs-full_SignificantInvestmentsInAssociatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInAssociatesAxis", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Associates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r20", "r22", "r64", "r140" ] }, "ifrs-full_SignificantInvestmentsInAssociatesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInAssociatesDomain", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used." } } }, "auth_ref": [ "r20", "r22", "r64", "r140" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r20", "r22", "r63", "r139" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesDomain", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r20", "r22", "r63", "r139" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r213" ] }, "ptgef_Stablecoin": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Stablecoin", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Stablecoin" } } }, "auth_ref": [] }, "ptgef_StablecoinSold": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StablecoinSold", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Stablecoin sold" } } }, "auth_ref": [] }, "ptgef_StablecoinUsedToPurchaseDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StablecoinUsedToPurchaseDigitalAssets", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stablecoin used to purchase digital assets" } } }, "auth_ref": [] }, "ptgef_StablecoinUsedToSettleOperatingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StablecoinUsedToSettleOperatingCosts", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Stablecoin used to settle operating costs" } } }, "auth_ref": [] }, "ptgef_StablecoinValueAsOfMarch31": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StablecoinValueAsOfMarch31", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Stablecoin value as of March 31" } } }, "auth_ref": [] }, "ptgef_StablecoinValueAsOfSeptember30": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StablecoinValueAsOfSeptember30", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Stablecoin value as of September 30" } } }, "auth_ref": [] }, "ptgef_Stablecoins": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Stablecoins", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails" ], "lang": { "en-us": { "role": { "label": "stablecoins" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetails", "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails", "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit", "http://portagebiotech.com/role/WarrantLiabilityDetails", "http://portagebiotech.com/role/WarrantLiabilityDetails1", "http://portagebiotech.com/role/WarrantLiabilityDetails2", "http://portagebiotech.com/role/WarrantLiabilityDetails3", "http://portagebiotech.com/role/WarrantLiabilityDetails4", "http://portagebiotech.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r153" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "ptgef_StevenMintzMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StevenMintzMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Steven Mintz [Member]" } } }, "auth_ref": [] }, "ptgef_StimunityMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StimunityMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative", "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stimunity [Member]" } } }, "auth_ref": [] }, "ptgef_StockOptionGrantedMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StockOptionGrantedMember", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Option Granted [Member]" } } }, "auth_ref": [] }, "ptgef_StockOptionReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StockOptionReserve", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Stock Option Reserve", "periodEndLabel": "Ending balance", "label": "Stock Option Reserve" } } }, "auth_ref": [] }, "ptgef_StockOptionReserveMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StockOptionReserveMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Option Reserve [Member]" } } }, "auth_ref": [] }, "ptgef_StockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StockOptionsMember", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails1", "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Stock Options [Member]" } } }, "auth_ref": [] }, "ptgef_StockbasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "StockbasedCompensation", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/IncomeTaxesDetails2": { "parentTag": "ifrs-full_NetDeferredTaxAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Share-based compensation" } } }, "auth_ref": [] }, "ptgef_SubsidiariesTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SubsidiariesTwoMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiaries Two [Member]" } } }, "auth_ref": [] }, "ptgef_SupplementalCashFlowInformationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "SupplementalCashFlowInformationsAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "auth_ref": [] }, "ptgef_TONMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TONMember", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "T O N [Member]" } } }, "auth_ref": [] }, "ptgef_TarusIPRDMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TarusIPRDMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Tarus IPR&D [Member]" } } }, "auth_ref": [] }, "ptgef_TaxDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TaxDeposits", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Tax deposits" } } }, "auth_ref": [] }, "ptgef_TaxUsingBviTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TaxUsingBviTaxRate", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Tax using BVI tax rate of 0%" } } }, "auth_ref": [] }, "ifrs-full_TerminationBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TerminationBenefitsExpense", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Termination benefits" } } }, "auth_ref": [ "r230" ] }, "ptgef_TokensArePayable": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TokensArePayable", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tokens are payable" } } }, "auth_ref": [] }, "ptgef_TokensUsedToSettlePutRights": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TokensUsedToSettlePutRights", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1", "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Tokens used to settle put rights" } } }, "auth_ref": [] }, "ptgef_TonPayableEndingBalanceAsOfMarch31": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TonPayableEndingBalanceAsOfMarch31", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails2" ], "lang": { "en-us": { "role": { "label": "TON payable as of March 31" } } }, "auth_ref": [] }, "ptgef_TonPayableToSettlePutRightsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TonPayableToSettlePutRightsExercised", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1", "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "TON payable to settle put rights exercised" } } }, "auth_ref": [] }, "ptgef_TonTokenPrice": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TonTokenPrice", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails" ], "lang": { "en-us": { "role": { "label": "TON token price" } } }, "auth_ref": [] }, "ptgef_TonTokenVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TonTokenVolatilityMember", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails" ], "lang": { "en-us": { "role": { "label": "Ton Token Volatility [Member]" } } }, "auth_ref": [] }, "ptgef_TonTokensFairValueInThousands": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TonTokensFairValueInThousands", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "TON Tokens, fair value (in thousands)" } } }, "auth_ref": [] }, "ptgef_TonTokensReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TonTokensReceivable", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "TON tokens receivable" } } }, "auth_ref": [] }, "ptgef_TonTokensReceivableShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TonTokensReceivableShares", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "TON tokens receivable shares" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://portagebiotech.com/role/BasisOfPresentationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r39", "r71", "r76", "r81", "r110", "r187", "r188", "r241" ] }, "ptgef_TotalCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TotalCurrentLiabilities", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Total Current Liabilities" } } }, "auth_ref": [] }, "ptgef_TotalLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TotalLeaseLiability", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/LeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Total lease liability" } } }, "auth_ref": [] }, "ptgef_TotalMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TotalMember", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1", "http://portagebiotech.com/role/PropertyPlantAndEquipmentAndRight-of-useAssetsDetails", "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails", "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Total [Member]" } } }, "auth_ref": [] }, "ptgef_TotalPrepaidExpensesAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TotalPrepaidExpensesAndOtherReceivables", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PrepaidExpensesAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Total prepaid expenses and other receivables" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r159" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r146", "r157", "r167" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ptgef_TransactionClosingBonus": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TransactionClosingBonus", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Transaction closing bonus" } } }, "auth_ref": [] }, "ptgef_TreasuryManagementAgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TreasuryManagementAgreementDescription", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Treasury Management Agreement description" } } }, "auth_ref": [] }, "ifrs-full_TreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TreasuryShares", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock", "label": "Treasury shares" } }, "en": { "role": { "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r23", "r198", "r203" ] }, "ptgef_TreasuryStock": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TreasuryStock", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Treasury stock" } } }, "auth_ref": [] }, "ptgef_TreasuryStockMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TreasuryStockMember", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Treasury Stock [Member]" } } }, "auth_ref": [] }, "ptgef_TreasuryStockObtainedInExchangeForReturnOfInvestmentInterestToCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TreasuryStockObtainedInExchangeForReturnOfInvestmentInterestToCompedica", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows", "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Treasury stock obtained in exchange for return of investment interest to Compedica", "negatedLabel": "Treasury stock obtained in exchange for return of investment interest to Compedica" } } }, "auth_ref": [] }, "ptgef_TreasuryStockObtainedInExchangeForReturnOfInvestmentInterestToCompedicaShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "TreasuryStockObtainedInExchangeForReturnOfInvestmentInterestToCompedicaShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfChangesInEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Treasury stock obtained in exchange for return of investment interest to Compedica , shares" } } }, "auth_ref": [] }, "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsAxis", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails", "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of antidilutive instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_TypesOfAntidilutiveInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsDomain", "presentation": [ "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails", "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used." } } }, "auth_ref": [ "r27" ] }, "ptgef_USD1Member": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "USD1Member", "presentation": [ "http://portagebiotech.com/role/ReceivablesDigitalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "U S D 1 [Member]" } } }, "auth_ref": [] }, "ptgef_USDCMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "USDCMember", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails", "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "U S D C [Member]" } } }, "auth_ref": [] }, "ptgef_UkLossCarryForwards": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "UkLossCarryForwards", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "UK Loss carry forwards" } } }, "auth_ref": [] }, "ptgef_UnbilledServices": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "UnbilledServices", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unbilled services" } } }, "auth_ref": [] }, "ptgef_UnrealizedLossOnChangeInFairValueOfDigitalAssetReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "UnrealizedLossOnChangeInFairValueOfDigitalAssetReceivables", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Unrealized loss on change in fair value of digital asset receivables" } } }, "auth_ref": [] }, "ptgef_UnrealizedLossOnChangeInFairValueOfDigitalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "UnrealizedLossOnChangeInFairValueOfDigitalAssets", "crdr": "debit", "calculation": { "http://portagebiotech.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Unrealized loss on change in fair value of digital assets" } } }, "auth_ref": [] }, "ptgef_UnrealizedLossesOnDigitalAssetsRecognizedInStatementOfOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "UnrealizedLossesOnDigitalAssetsRecognizedInStatementOfOperations", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/DigitalAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Unrealized losses on digital assets recognized in Statement of Operations" } } }, "auth_ref": [] }, "ptgef_Usd1Receivable": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "Usd1Receivable", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "USD1 receivable" } } }, "auth_ref": [] }, "ptgef_UsdtMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "UsdtMember", "presentation": [ "http://portagebiotech.com/role/StablecoinDetails", "http://portagebiotech.com/role/StablecoinDetails1" ], "lang": { "en-us": { "role": { "label": "Usdt [Member]" } } }, "auth_ref": [] }, "ptgef_UtilizationOfLossesNotPreviouslyBenefitted": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "UtilizationOfLossesNotPreviouslyBenefitted", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Utilization of losses not previously benefitted" } } }, "auth_ref": [] }, "ptgef_ValueOfSharesUsedToPurchaseInterestInCompedica": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "ValueOfSharesUsedToPurchaseInterestInCompedica", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Value of shares used to purchase interest in Compedica" } } }, "auth_ref": [] }, "ptgef_VestedStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "VestedStockOptionMember", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vested Stock Option [Member]" } } }, "auth_ref": [] }, "ifrs-full_WarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WarrantLiability", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://portagebiotech.com/role/FinancialInstrumentsAndRiskManagementDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrant liability", "label": "Warrant liability [Default Label]" } }, "en": { "role": { "documentation": "The amount of warrant liabilities." } } }, "auth_ref": [ "r247" ] }, "ptgef_WarrantsLiabilityFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "WarrantsLiabilityFairValue", "crdr": "debit", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, fair value at ending", "periodEndLabel": "Warrants outstanding, fair value at ending", "label": "WarrantsLiabilityFairValue" } } }, "auth_ref": [] }, "ptgef_WarrantsLiabilityShares": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "WarrantsLiabilityShares", "presentation": [ "http://portagebiotech.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, shares at ending", "periodEndLabel": "Warrants outstanding, shares at ending", "label": "WarrantsLiabilityShares" } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails1", "http://portagebiotech.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for warrants." } } }, "auth_ref": [ "r233" ] }, "ptgef_WarrantsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "WarrantsPerShare", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants" } } }, "auth_ref": [] }, "ptgef_WarrantsPurchase": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "WarrantsPurchase", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants purchase" } } }, "auth_ref": [] }, "ptgef_WarrantsToPurchase": { "xbrltype": "sharesItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "WarrantsToPurchase", "presentation": [ "http://portagebiotech.com/role/CapitalStockAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails3" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r79", "r134" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://portagebiotech.com/role/PutRightLiabilityAndTonPayableDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share price", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r78", "r80", "r133", "r135" ] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://portagebiotech.com/role/StockOptionReserveDetails3" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life (in years)" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r81" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding, Basic" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r26" ] }, "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract", "presentation": [ "http://portagebiotech.com/role/StatementsOfOperationsAndOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding" } } }, "auth_ref": [] }, "ptgef_WeightedAverageSharesOutstandingDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "WeightedAverageSharesOutstandingDiluted", "crdr": "credit", "presentation": [ "http://portagebiotech.com/role/LossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average shares outstanding, Diluted", "label": "WeightedAverageSharesOutstandingDiluted" } } }, "auth_ref": [] }, "ptgef_WesLevittMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "WesLevittMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1" ], "lang": { "en-us": { "role": { "label": "Wes Levitt [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://portagebiotech.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r224" ] }, "ptgef_YuryMitinMember": { "xbrltype": "domainItemType", "nsuri": "http://portagebiotech.com/20260331", "localname": "YuryMitinMember", "presentation": [ "http://portagebiotech.com/role/RelatedPartyTransactionsDetails1", "http://portagebiotech.com/role/RelatedPartyTransactionsDetails3" ], "lang": { "en-us": { "role": { "label": "Yury Mitin [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2025-03-27" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard", "URIDate": "2025-03-27" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2025-03-27" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2025-03-27" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard", "URIDate": "2025-03-27" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "74A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_74A_a&doctype=Standard", "URIDate": "2025-03-27" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "77", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_77_e&doctype=Standard", "URIDate": "2025-03-27" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard", "URIDate": "2025-03-27" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142&doctype=Standard", "URIDate": "2025-03-27" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2025-03-27" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard", "URIDate": "2025-03-27" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2025-03-27" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "32", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard", "URIDate": "2025-03-27" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2025-03-27" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2025-03-27" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_b&doctype=Standard", "URIDate": "2025-03-27" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2025-01-01", "Paragraph": "85", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_85_c&doctype=Standard", "URIDate": "2025-03-27" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "122", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_122_b&doctype=Standard", "URIDate": "2025-03-27" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard", "URIDate": "2025-03-27" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2025-03-27" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard", "URIDate": "2025-03-27" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2025-03-27" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI", "URIDate": "2025-03-27" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard", "URIDate": "2025-03-27" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard", "URIDate": "2025-03-27" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "44H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2025-03-27" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2025-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard", "URIDate": "2025-03-27" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "1", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_1&doctype=Standard", "URIDate": "2025-03-27" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_c&doctype=Standard", "URIDate": "2025-03-27" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2025-03-27" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2025-03-27" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2025-03-27" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B4", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Section": "Nature of the risks associated with an entity's interests in consolidated structured entities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS12_g14-17_TI", "URIDate": "2025-03-27" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2025-03-27" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2025-03-27" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2025-03-27" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard", "URIDate": "2025-03-27" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI", "URIDate": "2025-03-27" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2025-03-27" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2025-03-27" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2025-03-27" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2025-03-27" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2025-03-27" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard", "URIDate": "2025-03-27" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard", "URIDate": "2025-03-27" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2025-03-27" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "13C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_13C&doctype=Standard", "URIDate": "2025-03-27" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "24J", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_24J_b&doctype=Standard", "URIDate": "2025-03-27" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2025-03-27" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2025-03-27" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2025-03-27" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_36&doctype=Standard", "URIDate": "2025-03-27" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2025-03-27" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2025-03-27" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2025-03-27" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2025-03-27" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2025-03-27" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2025-03-27" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2025-03-27" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard", "URIDate": "2025-03-27" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard", "URIDate": "2025-03-27" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_g&doctype=Standard", "URIDate": "2025-03-27" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard", "URIDate": "2025-03-27" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard", "URIDate": "2025-03-27" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "168", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "169", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard", "URIDate": "2025-03-27" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "192", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard", "URIDate": "2025-03-27" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard", "URIDate": "2025-03-27" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard", "URIDate": "2025-03-27" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "202", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_202_c&doctype=Standard", "URIDate": "2025-03-27" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "204", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_204&doctype=Standard", "URIDate": "2025-03-27" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "218", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_a&doctype=Standard", "URIDate": "2025-03-27" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231&doctype=Standard", "URIDate": "2025-03-27" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "258", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_258_c&doctype=Standard", "URIDate": "2025-03-27" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "264", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_264_b&doctype=Standard", "URIDate": "2025-03-27" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "266", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard", "URIDate": "2025-03-27" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "269", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard", "URIDate": "2025-03-27" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "271", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard", "URIDate": "2025-03-27" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "273", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard", "URIDate": "2025-03-27" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "31", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "43", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard", "URIDate": "2025-03-27" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "71", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard", "URIDate": "2025-03-27" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2025-03-27" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_c&doctype=Standard", "URIDate": "2025-03-27" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard", "URIDate": "2025-03-27" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard", "URIDate": "2025-03-27" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard", "URIDate": "2025-03-27" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b", "URIDate": "2025-03-27" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_104&doctype=Standard", "URIDate": "2025-03-27" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard", "URIDate": "2025-03-27" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard", "URIDate": "2025-03-27" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard", "URIDate": "2025-03-27" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard", "URIDate": "2025-03-27" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_b&doctype=Standard", "URIDate": "2025-03-27" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_h&doctype=Standard", "URIDate": "2025-03-27" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard", "URIDate": "2025-03-27" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_k&doctype=Standard", "URIDate": "2025-03-27" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_o&doctype=Standard", "URIDate": "2025-03-27" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard", "URIDate": "2025-03-27" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard", "URIDate": "2025-03-27" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_56&doctype=Standard", "URIDate": "2025-03-27" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard", "URIDate": "2025-03-27" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard", "URIDate": "2025-03-27" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard", "URIDate": "2025-03-27" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard", "URIDate": "2025-03-27" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard", "URIDate": "2025-03-27" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard", "URIDate": "2025-03-27" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard", "URIDate": "2025-03-27" }, "r180": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "80", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2025-03-27" }, "r181": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2025-03-27" }, "r182": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2025-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r183": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2025-03-27" }, "r184": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r185": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI", "URIDate": "2025-03-27" }, "r186": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r187": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r188": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r189": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_118_d&doctype=Standard", "URIDate": "2025-03-27" }, "r190": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r191": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2025-03-27" }, "r192": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2025-03-27" }, "r193": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r194": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "103", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard", "URIDate": "2025-03-27" }, "r196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "193", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_a&doctype=Standard", "URIDate": "2025-03-27" }, "r197": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r198": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r199": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard", "URIDate": "2025-03-27" }, "r200": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r201": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard", "URIDate": "2025-03-27" }, "r202": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r203": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r204": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r205": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r206": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r207": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r211": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r212": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r213": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r214": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r215": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r216": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r217": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r218": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r219": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r220": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r222": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r223": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r224": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r225": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2025-03-27" }, "r227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81&doctype=Standard", "URIDate": "2025-03-27" }, "r228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2025-03-27" }, "r229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "158", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_158&doctype=Standard", "URIDate": "2025-03-27" }, "r230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "171", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_171&doctype=Standard", "URIDate": "2025-03-27" }, "r231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "5", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_5&doctype=Standard", "URIDate": "2025-03-27" }, "r232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2025-03-27" }, "r233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2025-03-27" }, "r234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard", "URIDate": "2025-03-27" }, "r235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard", "URIDate": "2025-03-27" }, "r236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard", "URIDate": "2025-03-27" }, "r237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2025-03-27" }, "r238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2025-03-27" }, "r239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard", "URIDate": "2025-03-27" }, "r243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard", "URIDate": "2025-03-27" }, "r244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard", "URIDate": "2025-03-27" }, "r245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard", "URIDate": "2025-03-27" }, "r246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard", "URIDate": "2025-03-27" } } }